<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>3
<FILENAME>a2073992zex-2_1.htm
<DESCRIPTION>EXHIBIT 2.1
<TEXT>
<HTML>
<HEAD>
<TITLE>
</TITLE>
</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>

<div style="font-family:'Times New Roman';">

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 2.1</font></b></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Execution Copy</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="border:none;border-top:double windowtext 9.0pt;padding:0in 0in 0in 0in;">

<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

</div>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">AGREEMENT AND PLAN OF MERGER</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dated as of March 19, 2002</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Among</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SCHERING AKTIENGESELLSCHAFT,</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">EUROPEAN ACQUISITION COMPANY</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">And</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">COLLATERAL THERAPEUTICS, INC.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<div style="border:none;border-bottom:double windowtext 9.0pt;padding:0in 0in 0in 0in;">

<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

</div>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=1,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=123591,FOLIO='',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="center" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TABLE OF CONTENTS</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;font-family:'Courier New';width:100.0%;">
 <tr style="font-family:'Times New Roman';">
  <td width="47%" colspan="2" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:47.48%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:43.24%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Page</font></u></p>
  </td>
 </tr>
 <tr style="font-family:'Times New Roman';">
  <td width="47%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:47.48%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" valign="top" style="padding:0in .7pt 0in .7pt;width:43.24%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="4" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:100.0%;">
  <p align="center" style="font-weight:bold;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#ArticleI" title="Click to goto ARTICLE I">ARTICLE I</a></font></b></p>
  </td>
 </tr>
 <tr>
  <td width="47%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:47.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="43%" valign="top" style="padding:0in .7pt 0in .7pt;width:43.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="4" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:100.0%;">
  <p align="center" style="font-weight:bold;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#TheMerger" title="Click to goto The Merger">The Merger</a></font></u></b></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
  <p align="center" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:center;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section1_01_" title="Click to goto SECTION 1.01.">SECTION 1.01.&#160; </a></font></b></p>
  </td>
  <td width="66%" colspan="2" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">The Merger</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">2</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section1_02_" title="Click to goto SECTION 1.02.">SECTION 1.02.&#160; </a></font></b></p>
  </td>
  <td width="66%" colspan="2" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Closing</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">2</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section1_03_" title="Click to goto SECTION 1.03.">SECTION 1.03.&#160; </a></font></b></p>
  </td>
  <td width="66%" colspan="2" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Effective Time</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">3</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section1_04_" title="Click to goto SECTION 1.04.">SECTION 1.04.&#160; </a></font></b></p>
  </td>
  <td width="66%" colspan="2" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Effects of the Merger</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">3</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section1_05_" title="Click to goto SECTION 1.05.">SECTION 1.05.</a></font></b></p>
  </td>
  <td width="66%" colspan="2" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Certificate of Incorporation and By-laws</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">3</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section1_06_" title="Click to goto SECTION 1.06.">SECTION 1.06.&#160; </a></font></b></p>
  </td>
  <td width="66%" colspan="2" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Directors</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">3</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="4" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:100.0%;">
  <p align="center" style="font-weight:bold;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#ArticleIi" title="Click to goto ARTICLE II">ARTICLE II</a></font></b></p>
  </td>
 </tr>
 <tr>
  <td width="47%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:47.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="43%" valign="top" style="padding:0in .7pt 0in .7pt;width:43.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="4" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:100.0%;">
  <p align="center" style="font-weight:bold;margin:0in 0in .0001pt .5in;text-align:center;text-indent:-.5in;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Effect of the Mer</font></u></b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">g<u>er on the Capital Stock of the Constituent Corporations; Exchange
  of Certificates</u></font></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section2_01_" title="Click to goto SECTION 2.01.">SECTION 2.01.&#160; </a></font></b></p>
  </td>
  <td width="66%" colspan="2" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Effect on Capital Stock</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">4</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section2_02_" title="Click to goto SECTION 2.02.">SECTION 2.02.&#160; </a></font></b></p>
  </td>
  <td width="66%" colspan="2" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Exchange of Certificates</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">5</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="4" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:100.0%;">
  <p align="center" style="font-weight:bold;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#RepresentationsAndWarranties" title="Click to goto Representations and Warranties">ARTICLE
  III</a></font></b></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="4" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
  <p align="center" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:center;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="4" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:100.0%;">
  <p align="center" style="font-weight:bold;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#RepresentationsAndWarranties" title="Click to goto Representations and Warranties">Representations and
  Warranties</a></font></u></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section3_01_" title="Click to goto SECTION 3.01.">SECTION 3.01.</a></font></b></p>
  </td>
  <td width="66%" colspan="2" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Representations and Warranties of <u>the
  Company</u></font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">9</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section3_02_" title="Click to goto SECTION 3.02.">SECTION 3.02.</a></font></b></p>
  </td>
  <td width="66%" colspan="2" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Representations and Warranties of Parent
  and Sub</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">31</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="4" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:100.0%;">
  <p align="center" style="font-weight:bold;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#CovenantsRelatingToConductOfBusines" title="Click to goto Covenants Relating to Conduct of Business">ARTICLE
  IV</a></font></b></p>
  </td>
 </tr>
 <tr>
  <td width="47%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:47.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="43%" valign="top" style="padding:0in .7pt 0in .7pt;width:43.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="4" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:100.0%;">
  <p align="center" style="font-weight:bold;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#CovenantsRelatingToConductOfBusines" title="Click to goto Covenants Relating to Conduct of Business">Covenants
  Relating to Conduct of Business</a></font></u></b></p>
  </td>
 </tr>
 <tr height="0">
  <td width="175" style="border:none;"></td>
  <td width="168" style="border:none;"></td>
  <td width="312" style="border:none;"></td>
  <td width="67" style="border:none;"></td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=2,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=249368,FOLIO='(i)',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="center" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:center;">&nbsp;</p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;font-family:'Courier New';width:100.0%;">
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section4_01_" title="Click to goto SECTION 4.01.">SECTION 4.01.&#160; </a></font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Conduct of Business</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">36</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section4_02_" title="Click to goto SECTION 4.02.">SECTION 4.02.&#160; </a></font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">No Solicitation</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">41</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="3" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:100.0%;">
  <p align="center" style="font-weight:bold;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#ArticleV" title="Click to goto ARTICLE V">ARTICLE V</a></font></b></p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:100.0%;">
  <p align="center" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:center;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="3" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:100.0%;">
  <p align="center" style="font-weight:bold;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#AdditionalAgreements" title="Click to goto Additional Agreements">Additional
  Agreements</a></font></u></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section5_01_" title="Click to goto SECTION 5.01.">SECTION
  5.01</a>.</font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Preparation of the Form F-4 and the <u>Proxy
  Statement; Company Stockholders&#146; Meeting</u></font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">45</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section5_02_" title="Click to goto SECTION 5.02.">SECTION 5.02.&#160; </a></font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Letters of the Company&#146;s Accountants</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">47</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section5_03_" title="Click to goto SECTION 5.03.">SECTION 5.03.&#160; </a></font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Letters of Parent&#146;s Accountants</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">47</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section5_04_" title="Click to goto SECTION 5.04.">SECTION 5.04.</a></font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Access to Information; Confidentiality</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">47</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section5_05_" title="Click to goto SECTION 5.05.">SECTION 5.05.&#160; </a></font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Commercially Reasonable Efforts</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">48</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section5_06_" title="Click to goto SECTION 5.06.">SECTION 5.06. </a></font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Treatment of Equity Awards</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">49</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section5_08_" title="Click to goto SECTION 5.08.">SECTION
  5.07.</a></font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Indemnification, Exculpation and Insurance</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">50</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section5_08_" title="Click to goto SECTION 5.08.">SECTION 5.08</a>.&#160; </font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Fees and Expenses</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">52</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section5_09_" title="Click to goto SECTION 5.09.">SECTION 5.09.&#160; </a></font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Public Announcements</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">53</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section5_10_" title="Click to goto SECTION 5.10.">SECTION 5.10.&#160; </a></font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Affiliates</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">54</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section5_11_" title="Click to goto SECTION 5.11.">SECTION 5.11.&#160; </a></font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Stock Exchange Listing</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">54</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section5_12_" title="Click to goto SECTION&#160;5.12.">SECTION 5.12.&#160; </a></font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Tax Treatment</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">54</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section5_14_" title="Click to goto SECTION 5.14.">SECTION
  5.13.&#160; </a></font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Stockholder Litigation</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">54</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section5_14_" title="Click to goto SECTION 5.14.">SECTION 5.14.</a>&#160; </font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Rights Agreement</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">54</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section5_15_" title="Click to goto SECTION 5.15.">SECTION 5.15.&#160; </a></font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Stockholders Agreement Legend</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">55</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section5_16_" title="Click to goto SECTION 5.16.">SECTION 5.16.</a></font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Transfer Taxes</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">55</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section5_17_" title="Click to goto SECTION 5.17.">SECTION 5.17.&#160; </a></font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Further Assurances</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">55</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section5_18_" title="Click to goto SECTION 5.18.">SECTION 5.18.&#160; </a></font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Section 16 Matters</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">55</font></b></p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=3,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=1002341,FOLIO='(ii)',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;font-family:'Courier New';width:100.0%;">
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#ArticleVi" title="Click to goto ARTICLE VI">SECTION
  5.19.&#160; </a></font></b></p>
  </td>
  <td width="66%" colspan="2" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Parent ADSs</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">56</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="4" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:100.0%;">
  <p align="center" style="font-weight:bold;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#ArticleVi" title="Click to goto ARTICLE VI">ARTICLE VI</a></font></b></p>
  </td>
 </tr>
 <tr>
  <td width="47%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:47.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="43%" valign="top" style="padding:0in .7pt 0in .7pt;width:43.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="4" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:100.0%;">
  <p align="center" style="font-weight:bold;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#ConditionsPrecedent" title="Click to goto Conditions Precedent">Conditions
  Precedent</a></font></u></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section6_01_" title="Click to goto SECTION 6.01.">SECTION 6.01.</a></font></b></p>
  </td>
  <td width="66%" colspan="2" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Conditions to Each Party&#146;s Obligation to
  Effect the Merger</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">56</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section6_02_" title="Click to goto SECTION 6.02.">SECTION 6.02.</a></font></b></p>
  </td>
  <td width="66%" colspan="2" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Conditions to Obligations of Parent and Sub</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">57</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section6_03_" title="Click to goto SECTION 6.03.">SECTION 6.03.</a></font></b></p>
  </td>
  <td width="66%" colspan="2" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Conditions to Obligation of the Company</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">58</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section6_04_" title="Click to goto SECTION 6.04.">SECTION 6.04.&#160; </a></font></b></p>
  </td>
  <td width="66%" colspan="2" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Frustration of Closing Conditions</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">59</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="4" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:100.0%;">
  <p align="center" style="font-weight:bold;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#ArticleVii" title="Click to goto ARTICLE VII">ARTICLE VII</a></font></b></p>
  </td>
 </tr>
 <tr>
  <td width="47%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:47.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="43%" valign="top" style="padding:0in .7pt 0in .7pt;width:43.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="4" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:100.0%;">
  <p align="center" style="font-weight:bold;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Termination, Amendment
  and Waiver</font></u></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section7_01_" title="Click to goto SECTION 7.01.">SECTION 7.01.</a></font></b></p>
  </td>
  <td width="66%" colspan="2" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Termination</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">59</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section7_02_" title="Click to goto SECTION 7.02.">SECTION 7.02.&#160; </a></font></b></p>
  </td>
  <td width="66%" colspan="2" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Effect of Termination</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">60</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section7_03_" title="Click to goto SECTION 7.03.">SECTION 7.03.&#160; </a></font></b></p>
  </td>
  <td width="66%" colspan="2" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Amendment</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">61</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section7_04_" title="Click to goto SECTION 7.04.">SECTION
  7.04.</a>&#160; </font></b></p>
  </td>
  <td width="66%" colspan="2" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Extension; Waiver</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">61</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="4" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:100.0%;">
  <p align="center" style="font-weight:bold;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#ArticleViii" title="Click to goto ARTICLE VIII">ARTICLE VIII</a></font></b></p>
  </td>
 </tr>
 <tr>
  <td width="47%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:47.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="43%" valign="top" style="padding:0in .7pt 0in .7pt;width:43.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="100%" colspan="4" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:100.0%;">
  <p align="center" style="font-weight:bold;margin:0in 0in .0001pt;text-align:center;text-indent:0in;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#GeneralProvisions" title="Click to goto General Provisions">General
  Provisions</a></font></u></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section8_01_" title="Click to goto SECTION 8.01.">SECTION 8.01.</a></font></b></p>
  </td>
  <td width="66%" colspan="2" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Nonsurvival of Representations and
  Warranties</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">61</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section8_02_" title="Click to goto SECTION 8.02.">SECTION 8.02.&#160; </a></font></b></p>
  </td>
  <td width="66%" colspan="2" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Notices</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">61</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section8_03_" title="Click to goto SECTION 8.03.">SECTION 8.03.&#160; </a></font></b></p>
  </td>
  <td width="66%" colspan="2" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Definitions</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">63</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" colspan="2" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section8_04_" title="Click to goto SECTION 8.04.">SECTION 8.04.&#160; </a></font></b></p>
  </td>
  <td width="66%" colspan="2" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Interpretation</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">64</font></b></p>
  </td>
 </tr>
 <tr height="0">
  <td width="175" style="border:none;"></td>
  <td width="168" style="border:none;"></td>
  <td width="312" style="border:none;"></td>
  <td width="67" style="border:none;"></td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=4,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=723497,FOLIO='(iii)',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;font-family:'Courier New';width:100.0%;">
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section8_05_" title="Click to goto SECTION 8.05.">SECTION 8.05.&#160; </a></font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Counterparts</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">65</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section8_06_" title="Click to goto SECTION 8.06.">SECTION 8.06.</a></font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Entire Agreement; No Third-Party
  Beneficiaries</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">65</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section8_07_" title="Click to goto SECTION 8.07.">SECTION 8.07.&#160; </a></font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Governing Law</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">65</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section8_08_" title="Click to goto SECTION 8.08.">SECTION 8.08.&#160; </a></font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Assignment</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">65</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section8_09_" title="Click to goto SECTION 8.09.">SECTION 8.09.</a></font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Enforcement; Consent to Jurisdiction</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">66</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" style="padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-size:12.0pt;font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="24%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:24.24%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;"><a href="#Section8_10_" title="Click to goto SECTION 8.10.">SECTION 8.10.&#160; </a></font></b></p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-weight:bold;margin:0in 0in .0001pt;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">Severability</font></b></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.28%;">
  <p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;text-indent:0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:normal;">67</font></b></p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="12%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:12.06%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Annex&nbsp;I</font></p>
  </td>
  <td width="12%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:12.46%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Index
  of Defined Terms</font></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.0%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">68</font></p>
  </td>
 </tr>
 <tr>
  <td width="12%" valign="top" style="padding:0in .7pt 0in .7pt;width:12.06%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="12%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:12.46%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.0%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="12%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:12.06%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit
  A</font></p>
  </td>
  <td width="12%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:12.46%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Form
  of Certificate of Incorporation of the Surviving Corporation</font></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.0%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="12%" valign="top" style="padding:0in .7pt 0in .7pt;width:12.06%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="12%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:12.46%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.0%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="12%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:12.06%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit
  B</font></p>
  </td>
  <td width="12%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:12.46%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Form
  of Affiliate Letter</font></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.0%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="12%" valign="top" style="padding:0in .7pt 0in .7pt;width:12.06%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="12%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:12.46%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.0%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="12%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:12.06%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit
  C-1</font></p>
  </td>
  <td width="12%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:12.46%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Form
  of Parent Tax Representation Letter</font></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.0%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="12%" valign="top" style="padding:0in .7pt 0in .7pt;width:12.06%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="12%" valign="bottom" style="padding:0in .7pt 0in .7pt;width:12.46%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" style="padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="9%" valign="top" style="padding:0in .7pt 0in .7pt;width:9.0%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="12%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:12.06%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit
  C-2</font></p>
  </td>
  <td width="12%" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:12.46%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="66%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:66.48%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Form
  of Company Tax Representation Letter</font></p>
  </td>
  <td width="9%" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:9.0%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=5,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=102331,FOLIO='(iv)',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>

<p style="margin:0in 0in .0001pt 1.5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">AGREEMENT AND PLAN OF MERGER (this
&#147;Agreement&#148;) dated as of March 19, 2002, among SCHERING AKTIENGESELLSCHAFT, a
stock corporation organized under the laws of the Federal Republic of Germany
(&#147;Parent&#148;), EUROPEAN ACQUISITION COMPANY, a Delaware corporation and a wholly
owned subsidiary of Parent (&#147;Sub&#148;), and COLLATERAL THERAPEUTICS, INC., a
Delaware corporation (the &#147;Company&#148;).</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">WHEREAS the Supervisory Board and the
Executive Board of Parent and the respective Boards of Directors of Sub and the
Company have each approved and declared advisable this Agreement and the merger
of Sub with and into the Company, upon the terms and subject to the conditions
set forth in this Agreement (the &#147;Merger&#148;), whereby each issued and outstanding
share of common stock, par value $.001 per share, of the Company (&#147;Company
Common Stock&#148;), other than shares of Company Common Stock owned by Parent, Sub,
the Company or Schering Berlin Inc. (&#147;SBI&#148;), will be converted into the right
to receive the Merger Consideration (as defined in Section&nbsp;2.01(c));</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">WHEREAS the Supervisory Board and the
Executive Board of Parent and the respective Boards of Directors of Sub and the
Company have each determined that the Merger and the other transactions
contemplated by this Agreement are consistent with, and in furtherance of,
their respective business strategies and goals;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">WHEREAS simultaneously with the execution
and delivery of this Agreement and as a condition and inducement to the
willingness of Parent and Sub to enter into this Agreement, Parent and certain
stockholders of the Company (the &#147;Principal Stockholders&#148;) are entering into an
agreement (the &#147;Stockholders Agreement&#148;) pursuant to which, among other things,
the Principal Stockholders have agreed to vote to adopt this Agreement, to
approve the Merger and to take certain other actions in furtherance of the
Merger upon the terms and subject to the conditions set forth in the
Stockholders Agreement;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">WHEREAS for U.S. Federal income tax
purposes, it is intended that (a)&nbsp;the Merger will qualify as a
reorganization within the meaning of Section&nbsp;368(a) of the Internal
Revenue Code of 1986, as amended (the &#147;Code&#148;), and the rules and</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=6,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=672430,FOLIO='',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">regulations
promulgated thereunder, (b)&nbsp;this Agreement will constitute a plan of
reorganization, (c)&nbsp;Parent, Sub and the Company will each be a party to
such reorganization within the meaning of Section&nbsp;368(b) of the Code and
(d) the Company stockholders who will not be &#147;five-percent transferee
shareholders&#148; as defined in Treasury Regulation Section 1.367(a)-3(c)(5)(ii) or
who enter into five-year gain recognition agreements in the form provided in
Treasury Regulation Section 1.367(a)-8(b) (&#147;Eligible Company Stockholders&#148;) and
who exchange Company Common Stock solely for Parent ADSs (as defined in
Section&nbsp;2.01(c)) pursuant to the Merger will not recognize taxable gain
with respect to the Merger pursuant to Section 367(a) of the Code (except with
respect to any cash received in lieu of fractional Parent ADSs); and</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">WHEREAS Parent, Sub and the Company desire
to make certain representations, warranties, covenants and agreements in
connection with the Merger and also to prescribe various conditions to the
Merger.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">NOW, THEREFORE, in consideration of the
representations, warranties, covenants and agreements contained in this
Agreement, the parties hereto agree as follows:</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><a name="ArticleI"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE
I</font></a></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><a name="TheMerger"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Merger</font></u></a></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section1_01_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
1.01.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>The Merger.</u>&#160; Upon the
terms and subject to the conditions set forth in this Agreement, and in
accordance with the General Corporation Law of the State of Delaware (the
&#147;DGCL&#148;), Sub shall be merged with and into the Company at the Effective Time.&#160; Following the Effective Time, the Company
shall be the surviving corporation in the Merger (the &#147;Surviving Corporation&#148;)
and shall succeed to and assume all the rights and obligations of Sub in
accordance with the DGCL.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section1_02_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
1.02.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Closing.</u>&#160; The closing of
the Merger (the &#147;Closing&#148;) shall take place at 10:00&nbsp;a.m. on a date to be
specified by the parties hereto (the &#147;Closing Date&#148;), which shall be no later
than the second business day after satisfaction or waiver of the conditions set
forth in Article&nbsp;VI (other than those conditions that by their nature are
to be</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=7,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=1035827,FOLIO='2',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">satisfied
at the Closing, but subject to the satisfaction or waiver of those conditions),
at the offices of Cravath, Swaine &amp; Moore, Worldwide Plaza, 825&nbsp;Eighth
Avenue, New&nbsp;York, New York 10019, unless another time, date or place is
agreed to by the parties hereto.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section1_03_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
1.03.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Effective Time.</u>&#160; Subject
to the provisions of this Agreement, as soon as practicable on or after the
Closing Date, the parties hereto shall file a certificate of merger or other
appropriate documents (in any such case, the &#147;Certificate of Merger&#148;) executed
in accordance with the relevant provisions of the DGCL and shall make all other
filings or recordings required under the DGCL.&#160;
The Merger shall become effective at such time as the Certificate of
Merger is duly filed with the Secretary of State of the State of Delaware, or
at such other time as Parent and the Company shall agree and specify in the
Certificate of Merger (the time the Merger becomes effective being hereinafter
referred to as the &#147;Effective Time&#148;).</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section1_04_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
1.04.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Effects of the Merger.</u>&#160;
The Merger shall have the effects set forth in Section 259 of the DGCL.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section1_05_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
1.05.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Certificate of Incorporation and By-laws.</u>&#160; (a)&nbsp;&nbsp;The Certificate of
Incorporation of the Surviving Corporation shall be amended at the Effective
Time to be in the form of Exhibit A hereto and, as so amended, such Certificate
of Incorporation shall be the Certificate of Incorporation of the Surviving
Corporation until thereafter changed or amended as provided therein or by
applicable law.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;
The By-laws of Sub, as in effect immediately prior to the Effective
Time, shall be the By-laws of the Surviving Corporation until thereafter changed
or amended as provided therein or by applicable law.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section1_06_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
1.06.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Directors.</u>&#160; The directors
of Sub immediately prior to the Effective Time shall be the directors of the
Surviving Corporation until the earlier of their resignation or removal or until
their respective successors are duly elected and qualified, as the case may be.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=8,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=891684,FOLIO='3',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><a name="ArticleIi"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE
II</font></a></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Effect of the Merger on the Capital
Stock of the</font></u></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Constituent Corporations; Exchange
of Certificates</font></u></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section2_01_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
2.01.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Effect on Capital Stock.</u>&#160;
As of the Effective Time, by virtue of the Merger and without any action
on the part of the holder of any shares of capital stock of the Company or any
shares of capital stock of Sub:</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;
<u>Capital Stock of Sub.</u>&#160;
Each issued and outstanding share of capital stock of Sub shall be
converted into and become one fully paid and nonassessable share of common
stock, par value $.001 per share, of the Surviving Corporation (&#147;Surviving
Corporation Common Stock&#148;).</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;
<u>Cancelation of Treasury Stock and Parent-Owned Stock.</u>&#160; Each share of Company Common Stock that is
owned by the Company, Parent or Sub shall automatically be canceled and shall
cease to be outstanding, and no Parent ADSs or other consideration shall be
delivered in exchange therefor; <u>provided</u>, <u>however</u>, that each
share of Company Common Stock that is owned by SBI shall not be so canceled and
shall remain outstanding as one fully paid and nonassessable share of Surviving
Corporation Common Stock.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;
<u>Conversion of Company Common Stock.</u>&#160; Subject to Section&nbsp;2.02(e), each issued and outstanding
share (other than shares to be canceled or to remain outstanding in accordance
with Section&nbsp;2.01(b)) of Company Common Stock shall be converted into the
right to receive 0.1847 (the &#147;Exchange Ratio&#148;) American depositary shares (each
a &#147;Parent ADS&#148;) of Parent (each Parent ADS representing the right to receive
one Ordinary Share, no par value, of Parent (&#147;Parent Ordinary Share&#148;) and
evidenced by one American depositary receipt (&#147;Parent ADR&#148;) issued in
accordance with the Deposit Agreement dated as of October&nbsp;11, 2000, as
amended from time to time (the &#147;Deposit Agreement&#148;), among Parent, Morgan
Guaranty Trust Company of New York (the &#147;Depositary&#148;), as depositary, and all
holders and beneficial owners from time to time of Parent ADRs) (the &#147;Merger
Consideration&#148;).&#160; As of the Effective
Time, all such shares of Company Common Stock shall no longer be outstanding
and shall automatically be canceled and shall cease to be outstanding, and each
holder of a certificate which immediately prior to the Effective Time
represented any such shares of Company Common Stock (each, a &#147;Certificate&#148;)
shall cease to have any rights with respect thereto, except the right to
receive the Merger </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=9,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=308813,FOLIO='4',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Consideration,
any dividends or other distributions to which such holder is entitled pursuant
to Section 2.02(c) and any cash in lieu of fractional Parent ADSs to which such
holder is entitled pursuant to Section&nbsp;2.02(e), in each case to be issued
or paid in consideration therefor upon surrender of such Certificate in
accordance with Section&nbsp;2.02(b), without interest.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;
<u>Anti-Dilution Provisions.</u>&#160;
Notwithstanding the foregoing, in the event that Parent changes the
number of Parent Ordinary Shares represented by each Parent ADS issued and
outstanding prior to the Effective Time as a result of a reclassification,
stock split, share combination, stock dividend or distribution,
recapitalization, merger, subdivision, issuer tender or exchange offer or other
similar transaction, the Exchange Ratio shall be appropriately adjusted to
reflect such reclassification, stock split, share combination, stock dividend
or distribution, recapitalization, merger, subdivision, issuer tender or
exchange offer or other similar transaction.&#160;
In addition, in the event Parent pays (or establishes a record date for
payment of) any dividend on, or makes any other distribution in respect of,
Parent Ordinary Shares (other than the regular dividend of </font><font size="2" style="font-size:10.0pt;">Euro</font><font size="2" style="font-size:10.0pt;">0.83
per Parent Ordinary Share), the Merger Consideration shall be appropriately
adjusted to reflect such dividend or distribution (other than the regular
dividend of Euro0.83 per Parent Ordinary Share).</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section2_02_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
2.02.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Exchange of Certificates.</u>&#160;
(a)&nbsp;&nbsp;<u>Exchange Agent.</u>&#160;
As of the Effective Time, Parent shall deposit with a U.S. bank or trust
company as may be designated by Parent (the &#147;Exchange Agent&#148;), for the benefit
of the holders of shares of Company Common Stock, for exchange in accordance
with this Article&nbsp;II, through the Exchange Agent, Parent ADRs representing
Parent ADSs issuable pursuant to Section&nbsp;2.01 in exchange for outstanding
shares of Company Common Stock.&#160; Parent
shall make available to the Exchange Agent from time to time as required after
the Effective Time cash necessary to pay dividends and other distributions in
accordance with Section&nbsp;2.02(c) and to make payments in lieu of any
fractional Parent ADSs in accordance with Section&nbsp;2.02(e) (such cash,
together with Parent ADSs representing the Merger Consideration, collectively,
the &#147;Exchange Fund&#148;).</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;
<u>Exchange Procedures.</u>&#160; As
soon as reasonably practicable after the Effective Time, the Exchange Agent
shall </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=10,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=496582,FOLIO='5',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">mail
to each holder of record of a Certificate whose shares of Company Common Stock
were converted into the right to receive the Merger Consideration pursuant to
Section&nbsp;2.01(c), (i)&nbsp;a letter of transmittal (which shall specify
that delivery shall be effected, and risk of loss and title to the Certificates
shall pass, only upon delivery of the Certificates to the Exchange Agent and
shall be in such form and have such other provisions as Parent may reasonably
specify) and (ii)&nbsp;instructions for use in surrendering the Certificates in
exchange for the Merger Consideration.&#160;
Upon surrender of a Certificate for cancelation to the Exchange Agent,
together with such letter of transmittal, duly executed, and such other
documents as may reasonably be required by the Exchange Agent, the holder of
such Certificate shall be entitled to receive in exchange therefor that number
of whole Parent ADSs which such holder has the right to receive pursuant to the
provisions of this Article&nbsp;II, any dividends or other distributions to
which such holder is entitled pursuant to Section&nbsp;2.02(c) and any cash in
lieu of fractional Parent ADSs to which such holder is entitled pursuant to
Section&nbsp;2.02(e), and the Certificate so surrendered shall forthwith be
canceled.&#160; In the event of a transfer of
ownership of shares of Company Common Stock which is not registered in the
transfer records of the Company, the proper amount of cash, if any, may be paid
and the proper number of Parent ADSs may be issued to a person other than the
person in whose name the Certificate so surrendered is registered, if such
Certificate shall be properly endorsed or otherwise be in proper form for
transfer and the person requesting such payment and issuance shall pay any
transfer or other taxes required by reason of the payment of any cash and the
issuance of Parent ADSs to a person other than the registered holder of such
Certificate or establish to the reasonable satisfaction of Parent that such tax
has been paid or is not applicable.&#160;
Until surrendered as contemplated by this Section&nbsp;2.02(b), each
Certificate shall be deemed at any time after the Effective Time to represent
only the right to receive upon such surrender the Merger Consideration, any
dividends or other distributions to which the holder of such Certificate is
entitled pursuant to Section&nbsp;2.02(c) and any cash in lieu of fractional
Parent ADSs to which such holder is entitled pursuant to
Section&nbsp;2.02(e).&#160; No interest shall
be paid or shall accrue on any cash payable to holders of Certificates pursuant
to the provisions of this Article&nbsp;II.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=11,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=217882,FOLIO='6',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;
<u>Distributions with Respect to Unexchanged Shares.</u>&#160; Any dividends or other distributions with
respect to Parent ADSs with a record date after the Effective Time shall be
paid to the holder of any unsurrendered Certificate with respect to the Parent
ADSs represented thereby, and any cash payment in lieu of fractional Parent
ADSs shall be paid to any such holder pursuant to Section&nbsp;2.02(e), in each
case only upon the surrender of such Certificate in accordance with this
Article&nbsp;II.&#160; Subject to the effect
of applicable abandoned property, escheat or similar laws, following surrender
of any such Certificate there shall be paid to the holder of the whole Parent
ADSs issued in exchange therefor, without interest, (i)&nbsp;at the time of
such surrender, the amount of dividends or other distributions with a record
date after the Effective Time theretofore paid with respect to such whole
Parent ADSs and the amount of any cash payable in lieu of a fractional Parent
ADSs to which such holder is entitled pursuant to Section&nbsp;2.02(e) and
(ii)&nbsp;at the appropriate payment date, the amount of dividends or other
distributions with a record date after the Effective Time but prior to such
surrender and with a payment date subsequent to such surrender payable with
respect to such whole Parent ADSs.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;
<u>No Further Ownership Rights in Company Common</u>  <u>Stock.</u>&#160; All Parent ADSs issued upon the surrender
for exchange of Certificates in accordance with the terms of this Article&nbsp;II
(including any cash paid pursuant to this Article&nbsp;II) shall be deemed to
have been issued (and paid) in full satisfaction of all rights pertaining to
the shares of Company Common Stock previously represented by such Certificates,
and there shall be no further registration of transfers on the stock transfer
books of the Surviving Corporation of the shares of Company Common Stock that
were outstanding immediately prior to the Effective Time.&#160; If, at any time after the Effective Time,
Certificates are presented to the Surviving Corporation or the Exchange Agent
for any reason, they shall be canceled and exchanged as provided in this
Article&nbsp;II.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)&#160;
<u>No Fractional Shares.</u> (i)&nbsp;&nbsp;No certificates or scrip
representing fractional Parent ADSs shall be issued upon the surrender for
exchange of Certificates, no dividend or other distribution of Parent shall
relate to such fractional share interests and such fractional share interests
shall not entitle the owner thereof to vote or to exercise any rights of a holder
of Parent ADSs.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=12,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=725524,FOLIO='7',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)&#160;
Parent shall cause to be paid to each former holder of shares of Company
Common Stock an amount in cash equal to the product obtained by multiplying
(A)&nbsp;the fractional share interest to which such former holder (after
taking into account all shares of Company Common Stock held at the Effective
Time by such holder) would otherwise be entitled by (B)&nbsp;the closing price
of a Parent Ordinary Share on the Closing Date, as such price is reported on
the Xetra system, translated into US dollars at the Euro/$ reference exchange
rate as of the Closing Date published by the European Central Bank and reported
on Reuters (page ECB37) and at <font style="color:blue;text-decoration:underline;"><u><font color="black" style="color:windowtext;">www.ecb.int.</font></u></font></font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)&#160;
As soon as practicable after the determination of the amount of cash, if
any, to be paid to holders of Certificates formerly representing Company Common
Stock with respect to any fractional share interests, the Exchange Agent shall
make available such amounts to such holders of Certificates formerly
representing Company Common Stock subject to and in accordance with the terms
of Section&nbsp;2.02(c).</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)&#160;
<u>Termination of Exchange Fund</u>.&#160;
Any portion of the Exchange Fund that remains undistributed to the
holders of the Certificates for twelve&nbsp;months after the Effective Time
shall be delivered to Parent, upon demand, and any holders of the Certificates
who have not theretofore complied with this Article&nbsp;II shall thereafter
look only to Parent for payment of their claim for the Merger Consideration,
any dividends or other distributions with respect to Parent ADSs and any cash
in lieu of fractional Parent ADSs in accordance with this Article II.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)&#160;
<u>No Liability.</u>&#160; None of
Parent, Sub, the Company or the Exchange Agent shall be liable to any person in
respect of any Merger Consideration, any dividends or other distributions with
respect thereto or any cash in lieu of fractional Parent ADSs, in each case
delivered to a public official pursuant to any applicable abandoned property,
escheat or similar law.&#160; If any
Certificate shall not have been surrendered prior to five years after the
Effective Time (or immediately prior to such earlier date on which any Merger
Consideration, any dividends or other distributions payable pursuant to
Section&nbsp;2.02(c) or any cash payable in lieu of fractional Parent ADSs
pursuant to Section&nbsp;2.02(e) would otherwise escheat to or become the
property of any Governmental Entity), any such Merger Consideration, dividends
or other distributions in respect thereof or such cash shall, to the</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=13,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=534947,FOLIO='8',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">extent
permitted by applicable law, become the property of Parent, free and clear of
all claims or interests of any person previously entitled thereto.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)&#160;
<u>Investment of Exchange Fund.</u>&#160;
The Exchange Agent shall invest any cash included in the Exchange Fund
in investment grade securities, as directed by Parent, on a daily basis.&#160; Any interest and other income resulting from
such investments shall be the property of, and shall be paid to, Parent.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)&#160;
<u>Lost Certificates.</u>&#160; If any
Certificate shall have been lost, stolen or destroyed, upon the making of an
affidavit of that fact by the person claiming such Certificate to be lost,
stolen or destroyed and, if required by Parent, the posting by such person of a
bond in such reasonable amount as Parent may direct as indemnity against any
claim that may be made against it with respect to such Certificate, the
Exchange Agent shall issue in exchange for such lost, stolen or destroyed
Certificate the Merger Consideration, any unpaid dividends or other
distributions in respect thereof and any cash in lieu of fractional Parent
ADSs, in each case pursuant to this Agreement.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(j)&#160;
<u>Withholding Rights.</u>&#160; The
Exchange Agent shall be entitled to deduct and withhold from the consideration
otherwise payable to any holder of shares of Company Common Stock pursuant to
this Agreement such amounts as may be required to be deducted and withheld with
respect to the making of such payment under the Code, or under any provision of
state, local or foreign tax law.&#160; To the
extent that amounts are so withheld and paid over to the appropriate taxing
authority, the Exchange Agent shall be treated as though it withheld an
appropriate amount of the type of consideration otherwise payable pursuant to
this Agreement to any holder of shares of Company Common Stock, sold such
consideration for an amount of cash equal to the fair market value of such
consideration at the time of such deemed sale and paid such cash proceeds to
the appropriate taxing authority.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><a name="ArticleIii"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE
III</font></a></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><a name="RepresentationsAndWarranties"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Representations and Warranties</font></u></a></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section3_01_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
3.01.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Representations and Warranties of</u>  <u>the Company.</u>&#160; Except as set forth in the disclosure
schedule (with</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=14,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=926691,FOLIO='9',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">specific
reference to the particular section or subsection of this Agreement to which
the information set forth in such disclosure schedule relates and such other
sections or subsections of this Agreement to the extent a matter is disclosed
in such a way as to make its relevance to the information called for by such
other section or subsection reasonably apparent) delivered by the Company to
Parent prior to the execution of this Agreement (the &#147;Company Disclosure
Schedule&#148;), the Company represents and warrants to Parent and Sub as follows:</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;
<u>Organization, Standing and Corporate Power.</u>&#160; The Company is a corporation duly organized,
validly existing and in good standing under the laws of the State of Delaware
and has all requisite corporate power and corporate authority and possesses all
governmental licenses, permits, authorizations and approvals necessary to
enable it to use its corporate name and to own, lease or otherwise hold and
operate its properties and other assets and to carry on its business as
presently conducted, except such governmental licenses, permits, authorizations
and approvals as, individually or in the aggregate, have not had and would not
reasonably be expected to have a Company Material Adverse Effect.&#160; The Company is duly qualified or licensed to
do business and is in good standing in each jurisdiction in which the nature of
its business or the ownership, leasing or operation of its properties or other
assets makes such qualification or licensing necessary, except for those
jurisdictions in which the failure to be so qualified or licensed or to be in
good standing individually or in the aggregate has not had and would not
reasonably be expected to have a Company Material Adverse Effect.&#160; The Company has made available to Parent
prior to the execution of this Agreement complete and correct copies of its
Second Restated Certificate of Incorporation (the &#147;Company Certificate&#148;) and
Restated By-laws (the &#147;Company By-laws&#148;), in each case as amended to the date
of this Agreement.&#160;&#160; The minute books of
the Company contain a complete and correct set of the minutes of all meetings
and accurately reflect all other actions taken by the stockholders of the
Company, the Board of Directors of the Company and all committees of the Board
of Directors of the Company.&#160; Complete
and correct copies of all such minute books have been provided by the Company
to Parent prior to the execution of this Agreement.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=15,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=956379,FOLIO='10',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;
<u>Subsidiaries.</u>&#160; The Company
does not own any capital stock or other ownership interest in any person.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;
<u>Capital Structure.</u>&#160; The
authorized capital stock of the Company consists of 40,000,000&nbsp;shares of
Company Common Stock and 5,000,000&nbsp;shares of preferred stock, par value
$.001 per share (&#147;Preferred Stock&#148;).&#160; At
the close of business on March 18, 2002, (i)&nbsp;13,357,492 shares of Company
Common Stock were issued and outstanding (including no restricted shares of
Company Common Stock the restrictions in respect of which lapse solely on the
basis of service of a Participant (as defined in Section&nbsp;3.01(g)) to the
Company), (ii)&nbsp;no shares of Company Common Stock were held by the Company
in its treasury, (iii)&nbsp;3,404,352 shares of Company Common Stock were
reserved for issuance pursuant to the Company Stock Plans (as defined in
Section&nbsp;5.06(a)) (of which 2,678,759 shares of Company Common Stock were
subject to outstanding stock options or other rights to purchase or receive
shares of Company Common Stock granted under the Company Stock Plans
(collectively, &#147;Company Stock Options&#148;)), (iv)&nbsp;no shares of Preferred
Stock were issued or outstanding and (v)&nbsp;40,000 shares of Series A Junior
Participating Preferred Stock were reserved for issuance in connection with the
Rights (as defined in Section&nbsp;5.14) issued pursuant to the Rights
Agreement (as defined in Section&nbsp;3.01(t)).&#160; Except as set forth above in this Section&nbsp;3.01(c), at the
close of business on March 18, 2002, no shares of capital stock or other voting
securities of the Company were issued, reserved for issuance or outstanding.&#160; Except as set forth above in this
Section&nbsp;3.01(c), there are no outstanding stock appreciation rights,
restricted shares, stock options, rights to receive shares of Company Common
Stock on a deferred basis or other rights that are linked to the value of
Company Common Stock granted under the Company Stock Plans or otherwise.&#160; Section&nbsp;3.01(c) of the Company
Disclosure Schedule sets forth a complete and accurate list, as of March 18,
2002, of all outstanding Company Stock Options granted under the Company Stock
Plans or otherwise, the number of shares of Company Common Stock subject
thereto, the grant dates, expiration dates, exercise prices and vesting
schedules thereof and the names of the holders thereof.&#160; All outstanding shares of capital stock of
the Company are, and all shares which may be issued will be, when issued, duly
authorized, validly issued, fully paid and nonassessable and, to the Knowledge
of the Company, will be delivered free and clear of all Liens (other than Liens
created by or imposed upon the holders thereof) and</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=16,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=1020257,FOLIO='11',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">not
subject to preemptive rights.&#160; There are
no bonds, debentures, notes or other indebtedness of the Company having the
right to vote (or convertible into, or exchangeable for, securities having the
right to vote) on any matters on which stockholders of the Company may
vote.&#160; Except as set forth above in this
Section&nbsp;3.01(c) (including pursuant to the conversion or exercise of the
securities referred to above), (i)&nbsp;there are not issued, reserved for
issuance or outstanding (A)&nbsp;any shares of capital stock or other voting
securities of the Company, (B)&nbsp;any securities of the Company convertible
into or exchangeable or exercisable for shares of capital stock or other voting
securities of, or other ownership interest in, the Company and (C)&nbsp;any
warrants, calls, options, &#147;phantom&#148; shares, stock appreciation rights,
restricted shares, stock-based performance units, commitments, contracts,
arrangements or undertakings or other rights to acquire from the Company, and
no obligation of the Company to issue, any capital stock or other voting
securities of, or other ownership interest in, or securities convertible into
or exchangeable or exercisable for capital stock or other voting securities of,
the Company, (ii)&nbsp;there are not any outstanding obligations of the Company
to repurchase, redeem or otherwise acquire any such securities or to issue,
deliver or sell, or cause to be issued, delivered or sold, any such securities
and (iii)&nbsp;the Company is not a party to any voting agreement with respect
to the voting of any such securities.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;
<u>Authority; Noncontravention.</u>&#160;
(i)&nbsp;The Company has all requisite corporate power and corporate
authority to enter into this Agreement and, subject to receipt of the Company
Stockholder Approval (as defined in Section&nbsp;3.01(p)), to consummate the
transactions contemplated by this Agreement.&#160;
The execution and delivery of this Agreement by the Company and the consummation
by the Company of the transactions contemplated by this Agreement have been
duly authorized by all necessary corporate action on the part of the Company
subject, in the case of the Merger, to the receipt of the Company Stockholder
Approval, and no other corporate proceedings on the part of the Company are
necessary to authorize this Agreement or to consummate the transactions
contemplated by this Agreement, subject, in the case of the Merger, to receipt
of the Company Stockholder Approval.&#160;
This Agreement has been duly executed and delivered by the Company and,
assuming the due authorization, execution and delivery by each of the other
parties hereto, constitutes a legal, valid and binding obligation of the </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=17,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=940186,FOLIO='12',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company,
enforceable against the Company in accordance with its terms.&#160; The Board of Directors of the Company, at a
meeting duly called and held at which all directors of the Company were
present, duly and unanimously adopted resolutions (A)&nbsp;approving this
Agreement and the Stockholders Agreement, the Merger and the other transactions
contemplated by this Agreement and the Stockholders Agreement,
(B)&nbsp;directing that the adoption of this Agreement be submitted to a vote
at a meeting of the stockholders of the Company, (C)&nbsp;recommending that the
stockholders of the Company adopt this Agreement and (D)&nbsp;declaring that
this Agreement is advisable.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)&#160;
The execution and delivery of this Agreement do not, and the
consummation of the Merger and the other transactions contemplated by this
Agreement and compliance with the provisions of this Agreement will not,
conflict with, or result in any violation or breach of, or default (with or
without notice or lapse of time, or both) under, or give rise to a right of, or
result in, termination, cancelation or acceleration of any obligation or to the
loss of a benefit under, or result in the creation of any pledge, claim, lien,
charge, encumbrance or security interest of any kind or nature whatsoever
(collectively, &#147;Liens&#148;) in or upon any of the properties or other assets of the
Company under, or give rise to any increased, additional, accelerated or
guaranteed rights or entitlements under, any provision of&#160; (A)&nbsp;the Company Certificate or Company
By-laws, (B)&nbsp;any loan or credit agreement, bond, debenture, note,
mortgage, indenture, lease or other contract, agreement, obligation,
commitment, arrangement, understanding, instrument, permit, concession,
franchise, license or similar authorization applicable to the Company or any of
its properties or other assets or (C)&nbsp;subject to the governmental filings
and other matters referred to in Section 3.01(d)(iii), any (1)&nbsp;statute,
law, ordinance, rule or regulation or (2)&nbsp;order, writ, injunction, decree,
judgment or stipulation, in each case applicable to the Company or any of its
properties or other assets, other than, in the case of
clauses&nbsp;(B)&nbsp;and (C), any such conflicts, violations, breaches,
defaults, rights, losses, Liens or entitlements that individually or in the
aggregate have not had and would not reasonably be expected to (x) have a
Company Material Adverse Effect, (y) impair the ability of the Company to
perform its obligations under this Agreement or (z) prevent or materially delay
the consummation of the transactions contemplated by this Agreement or the Stockholders
Agreement.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=18,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=188372,FOLIO='13',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)&#160;
No consent, approval, order or authorization of, action by or in respect
of, or registration, declaration or filing with, any Federal, state, local or
foreign government, any court, administrative, regulatory or other governmental
agency, commission or authority or any non-governmental self-regulatory agency,
commission or authority (each, a &#147;Governmental Entity&#148;) is required by or with
respect to the Company in connection with the execution and delivery of this
Agreement, the Stockholders Agreement or the consummation of the Merger or the
other transactions contemplated by this Agreement and the Stockholders
Agreement, except for (A)&nbsp;the filing of a premerger notification and
report form by the Company under the Hart-Scott-Rodino Antitrust Improvements
Act of 1976, as amended (the &#147;HSR Act&#148;), and any applicable filings and
approvals under similar foreign antitrust or competition laws and regulations,
(B)&nbsp;the filing with the Securities and Exchange Commission (the &#147;SEC&#148;) of
(1)&nbsp;a proxy statement relating to the Company Stockholders&#146; Meeting (such
proxy statement, as amended or supplemented from time to time, the &#147;Proxy
Statement&#148;) and (2)&nbsp;such reports under Section&nbsp;13(a), 13(d), 15(d) or
16(a) of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;),
as may be required in connection with this Agreement, the Stockholders
Agreement and the transactions contemplated by this Agreement or the
Stockholders Agreement, (C)&nbsp;the filing of the Certificate of Merger with
the Secretary of State of the State of Delaware and appropriate documents with
the relevant authorities of other jurisdictions in which the Company is
qualified to do business and (D)&nbsp;such other consents, approvals, orders,
authorizations, actions, registrations, declarations and filings the failure of
which to be obtained or made individually or in the aggregate has not had and
would not reasonably be expected to (x) have a Company Material Adverse Effect,
(y) impair the ability of the Company to perform its obligations under this
Agreement or (z) prevent or materially delay the consummation of the
transactions contemplated by this Agreement or the Stockholders Agreement.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)&#160;
<u>Company SEC Documents.</u>&#160;
The Company has filed all required reports, schedules, forms, statements
and other documents (including exhibits and all other information incorporated
therein) with the SEC since January 1, 2000 (collectively, the &#147;Company SEC
Documents&#148;).&#160; As of their respective
dates, the Company SEC Documents complied in all material respects with the
requirements of the Securities Act of</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=19,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=856063,FOLIO='14',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1933,
as amended (the &#147;Securities Act&#148;), or the Exchange Act, as the case may be, and
the rules and regulations of the SEC promulgated thereunder applicable to such
Company SEC Documents, and none of the Company SEC Documents at the time it was
filed contained any untrue statement of a material fact or omitted to state a
material fact required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they were made,
not misleading.&#160; Except to the extent
that information contained in any Company SEC Document filed and publicly
available prior to the date of this Agreement (the &#147;Filed Company SEC
Documents&#148;) has been revised or superseded by a later-filed Filed Company SEC
Document, none of the Company SEC Documents contains any untrue statement of
material fact or omits to state any material fact required to be stated therein
or necessary in order to make the statements therein, in light of the
circumstances under which they were made, not misleading.&#160; The financial statements (including the related
notes) included in the Company SEC Documents comply as to form in all material
respects with applicable accounting requirements and the published rules and
regulations of the SEC with respect thereto, have been prepared in accordance
with generally accepted accounting principles (&#147;GAAP&#148;) (except, in the case of
unaudited statements, as permitted by Form&nbsp;10-Q of the SEC) applied on a
consistent basis during the periods involved (except as may be indicated in the
notes thereto) and fairly present in all material respects the financial position
of the Company as of the dates thereof and its results of operations and cash
flows for the periods then ended (subject, in the case of unaudited statements,
to normal recurring year-end audit adjustments).&#160; Except as set forth in the most recent financial statements
included in the Filed Company SEC Documents, the Company has no liabilities or
obligations of any nature (whether accrued, absolute, contingent or otherwise)
which, individually or in the aggregate, have had or would reasonably be
expected to have a Company Material Adverse Effect.&#160; As of the date of this Agreement, the Company had cash and cash
equivalents and short-term investments, each as defined in the financial
statements included in the Filed Company SEC Documents, in the aggregate amount
of at least $4.7 million.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)&#160;
<u>Information Supplied.</u>&#160;
None of the information supplied or to be supplied by the Company
specifically for inclusion or incorporation by reference in (i)&nbsp;the
registration statement on Form F-4 to be filed with the SEC by Parent in </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=20,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=324393,FOLIO='15',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">connection
with the issuance of Parent ADSs in the Merger (the &#147;Form F-4&#148;) will, at the
time the Form&nbsp;F-4 becomes effective under the Securities Act, contain any
untrue statement of a material fact or omit to state any material fact required
to be stated therein or necessary to make the statements therein not misleading
or (ii)&nbsp;the Proxy Statement will, at the date it is first mailed to the
Company&#146;s stockholders or at the time of the Company Stockholders&#146; Meeting,
contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they are made, not misleading.&#160; The Proxy Statement will comply as to form
in all material respects with the requirements of the Exchange Act and the
rules and regulations promulgated thereunder.&#160;
No representation or warranty is made by the Company with respect to
statements made or incorporated by reference in the Proxy Statement based on
information supplied by Parent or Sub specifically for inclusion or
incorporation by reference in the Proxy Statement.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)&#160;
<u>Absence of Certain Changes or Events.</u>&#160; Except for liabilities incurred in connection with or expressly
permitted by this Agreement and except as disclosed in the Filed Company SEC
Documents, since December 31, 2001, the Company has conducted its business only
in the ordinary course consistent with past practice, and since such date there
has not been (i)&nbsp;any Company Material Adverse Change,&#160; (ii)&nbsp;any declaration, setting aside or
payment of any dividend or other distribution (whether in cash, stock or
property) with respect to any of the Company&#146;s capital stock, (iii)&nbsp;any split,
combination or reclassification of any of the Company&#146;s capital stock or any
issuance or the authorization of any issuance of any other securities in
respect of, in lieu of or in substitution for shares of the Company&#146;s capital
stock, (iv)&nbsp;(A)&nbsp;any granting by the Company to any current or former
director, officer or other employee of, or current or former independent
contractor with respect to, the Company (each, a &#147;Participant&#148;) of any increase
in compensation, bonus or other benefits, except for normal increases in cash
compensation in the ordinary course of business consistent with past practice,
(B) any commitment, contingent or otherwise, by the Company to pay any bonus to
any Participant (other than bonuses which have already been paid (which bonuses
amounted to $256,875 and which bonuses have been specified in Section
3.01(g)(iv)(B) of the Company Disclosure Schedule), (C)&nbsp;any granting by
the Company to any Participant of </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=21,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=665260,FOLIO='16',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">any
severance, change of control or termination pay or benefits (or any increase in
such pay or benefits), (D)&nbsp;any entry by the Company into, or any adoption
or amendment of, (1)&nbsp;any individual employment, deferred compensation,
consulting, severance, termination or indemnification agreement, arrangement or
understanding with any Participant or (2)&nbsp;any agreement with any
Participant the benefits of which are contingent, or the terms of which are
materially altered, upon the occurrence of a transaction involving the Company
of a nature contemplated by this Agreement (all such agreements under this
clause&nbsp;(D), collectively, &#147;Benefit Agreements&#148;) or (E) any amendment to,
or modification of, any Company Stock Option, (v) any damage, destruction or
loss, whether or not covered by insurance, that individually or in the
aggregate has had or would reasonably be expected to have a Company Material
Adverse Effect, (vi)&nbsp;any change in accounting methods, principles or
practices by the Company materially affecting its assets, liabilities or
businesses, except insofar as may have been required by a change in GAAP,
(vii)&nbsp;any material tax election or any settlement or compromise of any
material income tax liability or (viii) any disclosure by the Company or, to
the Knowledge of the Company, by any of its employees of any confidential
know-how (except by way of application for or issuance of a patent or pursuant
to a confidentiality agreement) or any lapse or abandonment of any patent or
patent application that is owned by the Company or with respect to which the
Company has an obligation to maintain pursuant to a license or other agreement.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)&#160;
<u>Litigation.</u>&#160; Except as
disclosed in the Filed Company SEC Documents, there is no investigation, suit,
claim, action, proceeding or grievance pending or, to the Knowledge of the
Company, threatened against the Company or specifically affecting the Company,
any of its employees (in connection with their employment by the Company) or
any of its products (it being understood that the foregoing does not include
matters affecting the pharmaceutical or biotechnical industry in general), by
any Governmental Entity or other person under any Legal Provision (as defined
in Section 3.01(j)) or otherwise, that individually or in the aggregate has had
or would reasonably be expected to have a Company Material Adverse Effect, nor
is there any judgment, decree, injunction, rule or order of any Governmental
Entity or arbitrator outstanding against the Company that individually or in
the aggregate has had or would reasonably be expected to have a Company
Material Adverse Effect.&#160; To the
Knowledge of the Company, there are no</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=22,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=816059,FOLIO='17',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">facts,
circumstances or conditions which could reasonably be expected to give rise to
any liability of, or form the basis of an investigation, suit, claim, action,
proceeding or grievance against, the Company or specifically affecting the
Company, any of its employees (in connection with their employment by the
Company) or any of its products (it being understood that the foregoing does
not include matters affecting the pharmaceutical or biotechnical industry in
general) relating to or arising under any applicable statutes, laws,
ordinances, rules or regulations, which liability, investigation, suit, claim,
action, proceeding or grievance, individually or in the aggregate, has had or
would reasonably be expected to have a Company Material Adverse Effect; <u>provided</u>,
<u>however</u>, that where this representation entails an evaluation of the
validity or enforceability of a patent or patent application, or of whether any
activity constitutes an infringement of a patent, then any such evaluation by
the Company is subject to the normal risks and uncertainties inherent in such
evaluations by patent counsel.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)&#160;
<u>Contracts.</u>&#160; Except as
disclosed in the Filed Company SEC Documents, the Company is not a party to,
and none of its properties or other assets are subject to, any contract or
agreement that is of a nature required to be filed as an exhibit to a report or
filing under the Securities Act or the Exchange Act and the rules and
regulations promulgated thereunder.&#160; The
Company is not in violation of or in default under (nor does there exist any
condition which upon the passage of time or the giving of notice or both would
cause such a violation of or default under) any loan or credit agreement, bond,
debenture, note, mortgage, indenture, lease or other contract, agreement,
obligation, commitment, arrangement, understanding, instrument, permit,
concession, franchise or license, whether oral or written, to which the Company
is a party or by which it or any of its properties or other assets is bound,
except for violations or defaults that individually or in the aggregate have
not had and would not reasonably be expected to have a Company Material Adverse
Effect.&#160; Except as disclosed in the
Filed Company SEC Documents, the Company has not entered into any amendment to
or modification of any license or any other material contract.&#160; The Company has not received written notice,
or to its Knowledge, oral notice, of its failure to comply with the terms of
any license or any other material contract to which it is a party.&#160; The Company has not entered into any
contract, agreement, obligation, commitment,</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=23,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=765217,FOLIO='18',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">arrangement
or understanding with any Affiliate of the Company that is currently in effect
other than agreements that are disclosed in the Filed Company SEC
Documents.&#160; The Company is not a party
to or otherwise bound by any agreement or covenant not to compete or by any
agreement or covenant restricting in any respect the development, marketing or
distribution of the Company&#146;s products or services.&#160; To the Knowledge of the Company, the Company is not party to or
otherwise bound by any agreement or covenant which would purport to limit in
any respect the manner in which, or the localities in which, Parent conducts
its business following the Effective Time.&#160;
Section&nbsp;3.01(i) of the Company Disclosure Schedule sets forth a
complete and accurate list of all contracts or agreements, to which the Company
is a party relating to the research, development, distribution, supply,
license, marketing or manufacturing by third parties of the Company&#146;s products
or products licensed by the Company.&#160;
The Company has made available to Parent complete and correct copies of
all such contracts or agreements.&#160; None
of such contracts and agreements grant an exclusive right (whether in the
present or upon happening of an event) to such third parties for the research,
development, distribution, supply, license, marketing or manufacturing of any
such product.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(j)&#160;
<u>Compliance with Laws.</u>&#160;
(i)&nbsp;&nbsp;The Company is in compliance with all statutes, laws,
ordinances, rules, regulations, judgments, orders and decrees of any
Governmental Entity applicable to it, its properties or other assets or its
business or operations (collectively, &#147;Legal Provisions&#148;), except for instances
of noncompliance that individually or in the aggregate have not had and would
not reasonably be expected to have a Company Material Adverse Effect.&#160; Except as, individually or in the aggregate,
has not had and would not reasonably be expected to have a Company Material
Adverse Effect, the Company has in effect all approvals, authorizations,
certificates, filings, franchises, licenses, notices, permits and rights of or
with all Governmental Entities, including all authorizations under the Federal
Food, Drug, and Cosmetic Act of 1938, as amended (the &#147;FDCA&#148;), and the
regulations of the Federal Food and Drug Administration (the &#147;FDA&#148;) promulgated
thereunder, and under Environmental Laws (collectively, &#147;Permits&#148;), necessary
for it to own, lease or operate its properties and other assets and to carry on
its business and operations as presently conducted.&#160; There has occurred no default under, or violation of, any such
Permit, except</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=24,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=487455,FOLIO='19',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">20</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">individually
or in the aggregate as has not had and would not reasonably be expected to have
a Company Material Adverse Effect.&#160; The
consummation of the Merger, in and of itself, would not cause the revocation or
cancelation of any such Permit that individually or in the aggregate would
reasonably be expected to have a Company Material Adverse Effect.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)&#160;
Except for those matters disclosed in the Filed Company SEC Documents
and those matters that individually or in the aggregate have not had and would
not reasonably be expected to have a Company Material Adverse Effect, (A) the
Company is, and has been, in compliance with all Environmental Laws;
(B)&nbsp;during the period of ownership or operation by the Company of any of
its currently or previously owned or operated properties, there have been no
Releases of Hazardous Material in, on, under or affecting such properties or
any surrounding sites; (C)&nbsp;prior to the period of ownership or operation
by the Company of any of its currently or previously owned or operated
properties, to the Knowledge of the Company, there were no Releases of
Hazardous Material in, on, under or affecting any such properties or any
surrounding sites; (D) there is no investigation, suit, claim, action,
proceeding or grievance pending, or to the Knowledge of the Company, threatened
against the Company or specifically affecting the Company, any of its employees
(in connection with their employment by the Company), any of its products or
any of its owned or leased real property (it being understood that the
foregoing does not include matters affecting the pharmaceutical or biotechnical
industry in general) relating to or arising under Environmental Laws, and the
Company has not received any notice of, or entered into or assumed by contract
or operation of law, any obligation, liability, order, settlement, judgment,
injunction or decree relating to or arising under Environmental Laws; and (E)
to the Knowledge of the Company, there are no facts, circumstances or
conditions which could reasonably be expected to give rise to any liability of,
or form the basis of an investigation, suit, claim, action, proceeding or grievance
against the Company or specifically affecting the Company, any of its employees
(in connection with their employment by the Company), any of its products or
any of its owned or leased real property (it being understood that the
foregoing does not include matters affecting the pharmaceutical or biotechnical
industry in general) relating to or arising under any Environmental Law which
liability, investigation, suit, claim, action, proceeding or grievance,
individually or in the aggregate, has had or would reasonably be </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=25,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=669413,FOLIO='20',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">expected
to have a Company Material Adverse Effect.&#160;
The term &#147;Environmental Laws&#148; means all Legal Provisions relating in any
way to the environment, preservation or reclamation of natural resources, the
presence, management, Release or threat of Release of, or exposure to,
Hazardous Materials, or to human health and safety.&#160; The term &#147;Hazardous Material&#148; means any chemical, material,
substance, waste, pollutant or contaminant that is prohibited, limited or
regulated by or pursuant to any Environmental Law.&#160; The term &#147;Release&#148; means any spilling, leaking, pumping, pouring,
emitting, emptying, discharging, injecting, escaping, leaching, dumping,
disposing or migrating into or through the environment or any natural or
man-made structure.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(k)&#160;
<u>Absence of Changes in Benefit Plans; Labor</u>  <u>Relations.</u>&#160; Except as disclosed in the Filed Company SEC
Documents, since the date of the most recent audited financial statements
included in the Filed Company SEC Documents, there has not been any adoption or
amendment (other than an amendment required by law) by the Company of any
Benefit Plan (as defined in Section&nbsp;3.01(l)) or any plan or arrangement
which would constitute a Benefit Plan if adopted or any material change in any
actuarial or other assumption used to calculate funding obligations with
respect to any Benefit Plan, or any change in the manner in which contributions
to any Benefit Plan are made or the basis on which such contributions are determined.&#160; Except as disclosed in the Filed Company SEC
Documents, there exist no currently binding Benefit Agreements.&#160; Since January&nbsp;1, 2000, the Company has
not encountered any labor union organizing activity or had any actual or
threatened employee strikes, work stoppages, slowdowns or lockouts.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(l)&#160;
<u>ERISA Compliance.</u>&#160;
(i)&nbsp;&nbsp;Section&nbsp;3.01(l)(i) of the Company Disclosure
Schedule contains a complete and correct list of each benefit, employment,
personal services,&#160; collective bargaining
(or other similar labor), compensation, incentive, stock option, restricted
stock, stock appreciation right, phantom equity, change of control, severance,
vacation, time-off, perquisite or other similar agreement, plan, policy or
other arrangement (and any amendments thereto), excluding any Benefit
Agreement, (A)&nbsp;covering one or more Participants, and maintained by the
Company or (B)&nbsp;with respect to which the Company has or could have any
liability (each, a &#147;Benefit Plan&#148;).&#160; The
Company has made available to Parent complete and correct copies of
(A)&nbsp;each Benefit Plan (or, in the case of any</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=26,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=122079,FOLIO='21',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">22</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">unwritten
Benefit Plans, descriptions thereof) and each Benefit Agreement, (B)&nbsp;the
two most recent annual reports on Form&nbsp;5500 required to be filed with the
Internal Revenue Service (the &#147;IRS&#148;) with respect to each Benefit Plan (if any
such report was required), (C)&nbsp;the most recent summary plan description
for each Benefit Plan for which such summary plan description is required and
(D)&nbsp;each trust agreement and insurance or group annuity contract relating
to any Benefit Plan.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)&#160;
Each Benefit Plan, the Company, its officers and those with discretion
relating to any Benefit Plan&#146;s assets or administration have at all times
complied with the applicable requirements of all applicable laws, including the
Employee Retirement Income Security Act of 1974, as amended (&#147;ERISA&#148;), and the
regulations promulgated thereunder, except where the failure to comply,
individually or in the aggregate, has not had and would not reasonably be
expected to have a Company Material Adverse Effect, and, each Benefit Plan has,
at all times in order to obtain pension related taxation advantages, complied,
in all material respects, with the Code, and the regulations promulgated
thereunder.&#160; To the Knowledge of the
Company, neither the Company nor any Affiliate of the Company has, or could
reasonably be expected to incur, any unfunded liabilities in relation to any
Benefit Plan or any Participant (other than liabilities relating to claims for
welfare benefits in the normal course), and all payments, benefits,
contributions and premiums relating to each Benefit Plan have been timely paid
or made in accordance with the terms of such Benefit Plan and the terms of all
applicable laws.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)&#160;
(A) No Benefit Agreement or Benefit Plan (1)&nbsp;provides for defined
benefit pension benefits, or deferred compensation, (2)&nbsp;provides any
benefits (other than on a self-pay basis or pursuant to the terms of a Benefit
Agreement) following termination of service or employment, (3)&nbsp;is a
&#147;multiple employer welfare arrangement&#148; (as defined in Section&nbsp;3(40) of
ERISA), is subject to Title IV of ERISA, or is a &#147;multiemployer plan&#148; (within
the meaning of Section&nbsp;4001(a)(3) of ERISA or other applicable employee
benefit legislation), (4) is a collective bargaining or similar labor
agreement, (5)&nbsp;covers any Participant who resides or works outside the
United States and (B) no Participant (1) is represented by any union, (2) is
currently receiving any disability benefits, (3) has entered into or is covered
by any Benefit Agreement or any other individual agreement or arrangement with
the Company or </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=27,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=673511,FOLIO='22',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">23</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">any
of its Affiliates or stockholders, (4) has received any loan from the Company
or any Affiliate of the Company which has an outstanding balance, (5) has a
right (x)&nbsp;to take more than four weeks of vacation per year or (y)&nbsp;to
receive from the Company or any Affiliate of the Company base annual salary in excess
of $80,000, a guaranteed bonus, or a target or discretionary bonus (with
respect to any single year) in excess of $25,000, (6) has received from the
Company or any Affiliate of the Company, and neither the Company nor any
Affiliate of the Company has agreed to provide to any Participant, any
discretionary severance or any severance under any formal or informal policy or
practice, (7) has received or could reasonably be expected to receive any
payment or benefit from the Company or any Affiliate of the Company which would
not be deductible to such entity or (8) is, or at any time will become,
entitled to any payment, benefit or right, or any increased and/or accelerated
payment, benefit or right, as a result of (x) such Participant&#146;s termination of
employment with, or services to, the Company or any Affiliate of the Company or
any successor to the Company or (y)&nbsp;the execution of this Agreement or the
consummation of the transactions contemplated by this Agreement.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(m)&#160;
<u>Taxes.</u>&#160; (i)&nbsp;The
Company has filed or has caused to be filed all tax returns and reports
required to be filed by it and all such returns and reports are complete and
accurate in all material respects.&#160; The
Company has paid or caused to be paid all taxes shown to be due on such returns
and reports, and the most recent financial statements contained in the Filed
Company SEC Documents reflect an adequate reserve (excluding any reserves for
deferred taxes) for all taxes payable by the Company for all taxable periods
and portions thereof accrued through the date of such financial statements.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)&#160;
No deficiencies, audit examinations, refund litigation, proposed
adjustments or matters in controversy for any taxes have been proposed,
asserted or assessed in writing against the Company.&#160; The Federal income tax returns of the Company have not been
examined by or settled with the IRS for any taxable years of the Company.</font><font size="2" style="font-size:10.0pt;">  </font><font size="2" style="font-size:10.0pt;">&#160;All assessments for taxes due and owing by
the Company with respect to completed and settled examinations or concluded
litigation have been paid.&#160; There is no
currently effective agreement or other document extending, or having the effect
of extending, the period of assessment or collection of any taxes.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=28,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=985061,FOLIO='23',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">24</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)&#160;
The Company will not be required to include in a taxable period ending
after the Effective Time taxable income attributable to income that accrued in
a prior taxable period but was not recognized for tax purposes in any prior
taxable period as a result of the installment method of accounting, the
completed contract method of accounting, the long-term contract method of
accounting, the cash method of accounting or Section 481 of the Code or similar
provisions of Federal, state, local or other domestic or foreign tax law.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)&#160;
The Company has not taken or agreed to take any action and does not know
of any fact, agreement, plan or other circumstance that is reasonably likely to
(A)&nbsp;prevent the Merger from qualifying as a reorganization within the
meaning of Section&nbsp;368(a) of the Code or (B)&nbsp;cause the Eligible
Company Stockholders who exchange Company Common Stock solely for Parent ADSs
pursuant to the Merger to recognize taxable gain with respect to the Merger
pursuant to Section 367(a) of the Code (except with respect to any cash
received in lieu of fractional Parent ADSs).</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(v)&#160;
The Company has not constituted either a &#147;distributing corporation&#148; or a
&#147;controlled corporation&#148; in a distribution of stock qualifying for tax-free
treatment under Section&nbsp;355 of the Code (A)&nbsp;in the two years prior to
the date of this Agreement or (B)&nbsp;in a distribution which could otherwise
constitute part of a &#147;plan&#148; or &#147;series of related transactions&#148; (within the
meaning of Section&nbsp;355(e) of the Code) in conjunction with the Merger.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(vi)&#160;
As used in this Agreement,&nbsp;&#148;taxes&#148; shall include all
(A)&nbsp;Federal, state, local and foreign income, property, sales, excise,
withholding and other taxes and similar governmental charges, including any
interest, penalties and additions with respect thereto, (B)&nbsp;liability for
the payment of any amounts of the type described in clause (A) as a result of
being a member of a consolidated, combined or similar group and
(C)&nbsp;liability as a result of any tax sharing or similar contractual
agreement.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(n)&#160;
<u>Title to Properties</u>. &#160;(i)&nbsp;&nbsp;The Company has good and marketable title to, or
valid leasehold interests in, all real properties owned or leased by the
Company except for such as are no longer used or useful in the conduct of its
business or as have been disposed of in the ordinary course of business </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=29,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=528445,FOLIO='24',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">25</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">and
except for defects in title, easements, restrictive covenants and similar
encumbrances that individually or in the aggregate would not materially
interfere with its ability to conduct its business as presently conducted.&#160; All such properties, other than properties
in which the Company has a leasehold interest, are free and clear of all Liens,
except for Liens that individually or in the aggregate would not materially
interfere with the ability of the Company to conduct its business as presently
conducted.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)&#160;
The Company has complied in all material respects with the terms of all
material leases to which it is a party and under which it is in occupancy, and
all such leases are in full force and effect, except for such noncompliance or
failure to be in full force and effect that individually or in the aggregate
has not had and would not reasonably be expected to have a Company Material
Adverse Effect.&#160; The Company is in occupancy
and possession under all such leases.&#160;
The Company has not received any notice from any third party of a fact
that could reasonably be expected to be detrimental to the continued occupancy
and possession by the Company under all leases to which it is a party and under
which it is in occupancy.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(o)&#160;
<u>Intellectual Property</u>. (i)&#160;
To the Knowledge of the Company, the Company owns, or is validly
licensed or otherwise has the right to use (without any obligation to make any
fixed or contingent payments, including royalty payments (except as provided in
Section 3.01(o)(v) of the Company Disclosure Schedule)) all patents, patent
applications, trademarks, trademark applications, trademark rights, trade
names, trade name rights, domain names, service marks, service mark rights,
copyrights, copyright applications, software, technical know-how and other
proprietary intellectual property rights and computer programs (collectively,
&#147;Intellectual Property Rights&#148;) which are material (A) to the conduct of the
business of the Company as it is currently conducted and (B) to the research,
development, use, manufacture and sale of any Pharmaceutical Product (as
defined in Section 3.01(u)) (but only to the extent that any Pharmaceutical
Product is researched, developed, used manufactured or sold currently by the
Company) free and clear of all Liens.&#160;
To the extent that this representation entails an evaluation of the
validity or enforceability of a patent or patent application, or of whether any
activity constitutes an infringement of a patent, then any such evaluation by
the Company is subject to the normal risks</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=30,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=102810,FOLIO='25',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">26</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">and
uncertainties inherent in such evaluations by patent counsel.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)&#160;
To the Knowledge of the Company, no person or persons are infringing the
rights of the Company with respect to any Intellectual Property Right in a
manner which, individually or in the aggregate, has had or would reasonably be
expected to have a Company Material Adverse Effect.&#160; To the extent that this representation entails an evaluation of
the validity or enforceability of a patent or patent application, or of whether
any activity constitutes an infringement of a patent, then any such evaluation
by the Company is subject to the normal risks and uncertainties inherent in
such evaluations by patent counsel.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)&#160;
Section&nbsp;3.01(o)(iii) of the Company Disclosure Schedule sets forth,
as of the date of this Agreement, a complete and correct list (by category) of
all patents, trademarks and applications therefor owned by or licensed to the
Company.&#160; All such patents, trademarks
and applications therefor listed in Section 3.01(o)(iii) of the Company
Disclosure Schedule are owned by or validly licensed to the Company (without
any obligation to make any fixed or contingent payments, including royalty
payments (except as provided in Section 3.01(o)(v) of the Company Disclosure
Schedule)) free and clear of all Liens.&#160;
The patent applications listed in Section 3.01(o)(iii) of the Company
Disclosure Schedule are pending and have not been abandoned, and have been and
continue to be prosecuted by registered patent counsel.&#160; The Company has no Knowledge of any fact,
circumstance or condition that could reasonably be expected to prevent any
pending patent application from being granted to the extent such pending patent
application is material to the Company&#146;s business; <u>provided</u>, <u>however</u>,
that where this statement entails an evaluation of the validity or
enforceability of a patent or patent application, or of whether any activity
constitutes an infringement of a patent, then any such evaluation by the
Company is subject to the normal risks and uncertainties inherent in such
evaluations by patent counsel.&#160; All
patents, trademarks and applications therefor owned by or licensed to the
Company have been duly registered and/or filed with or issued by each
appropriate Governmental Entity in the jurisdiction indicated in Section
3.01(o)(iii) of the Company Disclosure Schedule, all necessary affidavits of
continuing use have been filed and all necessary maintenance fees have been
timely paid to continue all such rights in </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=31,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=943473,FOLIO='26',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">27</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">effect.&#160; None of the patents listed in Section
3.01(o)(iii) of the Company Disclosure Schedule has expired or has been
declared invalid, in whole or in part, by any Governmental Entity.&#160; There are no ongoing interferences,
oppositions, reissues, reexaminations or adverse proceedings involving any of
the patents or patent applications listed in Section 3.01(o)(iii) of the
Company Disclosure Schedule, including ex parte and post-grant proceedings, in
the United States Patent and Trademark Office or in any foreign patent office
or similar administrative agency.&#160; To
the Knowledge of the Company, there are no published patents, patent
applications, articles or other prior art references that could materially
affect the validity of any patent listed in Section 3.01(o)(iii) of the Company
Disclosure Schedule</font><b><font size="2" style="font-size:10.0pt;font-weight:bold;">; </font></b><u><font size="2" style="font-size:10.0pt;">provided</font></u><font size="2" style="font-size:10.0pt;">, <u>however</u>,
that where this statement entails an evaluation of the validity or
enforceability of a patent or patent application, or of whether any activity
constitutes an infringement of a patent, then any such evaluation by the
Company is subject to the normal risks and uncertainties inherent in such
evaluations by patent counsel.&#160; To the
Knowledge of the Company, there are no patents owned by third parties (other
than patents licensed by the Company) that are considered likely to prevent the
conduct of the Company&#146;s business as it is currently being conducted; <u>provided</u>,
<u>however</u>, that where this statement entails an evaluation of the validity
or enforceability of a patent or patent application, or of whether any activity
constitutes an infringement of a patent, then any such evaluation by the Company
is subject to the normal risks and uncertainties inherent in such evaluations
by patent counsel.&#160; The inventions
described in the patents and patent applications listed in Section 3.01(o)(iii)
of the Company Disclosure Schedule have been assigned or are obligated to be
assigned to the Company or to a licensor of the Company, and are subject to no
contractual or other obligation that would preclude any such assignment or
otherwise conflict with the obligation to assign such invention(s) to the
Company or to a licensor of the Company.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)&#160;
Section 3.01(o)(iv) of the Company Disclosure Schedule sets forth a
complete and correct list of all options and licenses relating to Intellectual
Property Rights granted to the Company, other than software licenses for
generally available software, or granted by the Company to any other person.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=32,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=528427,FOLIO='27',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">28</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (v)&#160;
None of the execution and delivery of this Agreement, the obtaining of
the Company Stockholder Approval or the consummation of the Merger or any other
transaction contemplated by this Agreement will (A)&nbsp;entitle any third
party to any royalty or other payment under any Intellectual Property Right of
the Company or (B)&nbsp;accelerate the time of any royalty or other payment or
trigger any royalty or other payment, increase the amount of any royalty or
other payment or trigger any other material obligation under any Intellectual
Property Right of the Company.&#160; Section
3.01(o)(v) of the Company Disclosure Schedule sets forth a complete and correct
list of all royalty and other payments payable by the Company pursuant to
agreements with third parties, or to the Knowledge of the Company, to any third
party in any other circumstance, for the use of Intellectual Property Rights licensed
by or used by the Company in connection with the research, development, use,
manufacture or sale of any Pharmaceutical Product.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(p)&#160;
<u>Voting Requirements.</u>&#160; The
affirmative vote at the Company Stockholders&#146; Meeting of holders of a majority
of the outstanding shares of Company Common Stock to adopt this Agreement (the
&#147;Company Stockholder Approval&#148;) is the only vote of the holders of any class or
series of the Company&#146;s capital stock necessary to adopt this Agreement and
approve the Merger and the other transactions contemplated by this
Agreement.&#160; Each Principal Stockholder
is the record owner of, or is the trustee of a trust that is the record holder
of, the number of Subject Shares (as such term is defined in the Stockholders
Agreement) set forth beside the name of such Stockholder on Schedule A to the
Stockholders Agreement.&#160; As of the date
of this Agreement, the Subject Shares represent in the aggregate not less than
26.67% of the outstanding shares of Company Common Stock.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(q)&#160;
<u>State Takeover Statutes.</u>&#160;
The Board of Directors of the Company has unanimously approved the terms
of this Agreement and the Stockholders Agreement and the consummation of the
Merger and the other transactions contemplated by this Agreement and the
Stockholders Agreement, and such approval constitutes approval of the Merger
and the other transactions contemplated by this Agreement and the Stockholders
Agreement by the Board of Directors of the Company under the provisions of
Section&nbsp;203 of the DGCL and represents all the action necessary to ensure
that the restrictions on &#147;business combinations&#148; (as defined in such
Section&nbsp;203) contained in such Section&nbsp;203 do not apply to Parent in
connection with the Merger and the other</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=33,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=836005,FOLIO='28',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">29</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">transactions
contemplated by this Agreement and the Stockholders Agreement.&#160; No other state takeover statute or similar
statute or regulation applies or purports to apply to this Agreement, the
Stockholders Agreement, the Merger or the other transactions contemplated by
this Agreement and the Stockholders Agreement.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(r)&#160; <u>Brokers and Other Advisors.</u>&#160; No broker, investment banker, financial
advisor or other person, other than Bear, Stearns&nbsp;&amp; Co. Inc., the
fees, commissions and expenses of which will be paid by the Company, is
entitled to any broker&#146;s, finder&#146;s, financial advisor&#146;s or other similar fee or
commission, or the reimbursement of expenses, in connection with the
transactions contemplated by this Agreement and the Stockholders Agreement
based upon arrangements made by or on behalf of the Company.&#160; The Company has delivered to Parent complete
and correct copies of all agreements under which any such fees, commissions or
expenses are payable and all indemnification and other agreements related to the
engagement of the persons to whom such fees, commissions or expenses are
payable.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(s)&#160;
<u>Opinion of Financial Advisor.</u>&#160;
The Company has received the opinion of Bear, Stearns &amp; Co. Inc.
dated the date of this Agreement, to the effect that, as of such date, the
Merger Consideration is fair, from a financial point of view, to the public
stockholders of the Company (other than Parent and its Affiliates), a signed
copy of which opinion has been or promptly will be delivered to Parent.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(t)&#160;
<u>Rights Agreement.</u>&#160; The
Company has taken all actions necessary to cause the Rights Agreement dated as
of September&nbsp;19, 2001, between the Company and American Stock
Transfer&nbsp;&amp; Trust Company, as rights agent (the &#147;Rights Agreement&#148;) to
be amended to (i)&nbsp;render the Rights Agreement inapplicable to this
Agreement, the Stockholders Agreement, the Merger and the other transactions
contemplated by this Agreement and the Stockholders Agreement, (ii)&nbsp;ensure
that (A)&nbsp;none of Parent, Sub or any other subsidiary of Parent is an
Acquiring Person (as defined in the Rights Agreement) pursuant to the Rights
Agreement and (B)&nbsp;a Distribution Date, a Triggering Event or a Shares
Acquisition Date (as such terms are defined in the Rights Agreement) does not
occur, in either case of clauses&nbsp;(A) and (B), solely by reason of the
execution of this Agreement or the Stockholders Agreement or the consummation
of the Merger or the other transactions contemplated by this Agreement and the </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=34,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=48267,FOLIO='29',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Stockholders
Agreement and (iii)&nbsp;provide that the Final Expiration Date (as defined in
the Rights Agreement) shall occur immediately prior to the Effective Time.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(u)&#160;
<u>Regulatory Compliance.</u>&#160;
(i)&nbsp;&nbsp;The Company has never manufactured, shipped or marketed,
and does not currently manufacture, ship or market, any product subject to the
FDCA and the FDA regulations thereunder (each such product, a &#147;Pharmaceutical
Product&#148;) for clinical trials or sales.&#160;&#160;
The Company has not engaged in and is not currently engaging in any activities
which are subject to the FDCA and the FDA regulations thereunder.&#160; The Company has not made any filings with
the FDA or equivalent state or foreign regulatory agency, including any
biologics license application, new drug application or investigational new drug
application.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)&#160;
Neither the Company nor any officer, employee or agent of the Company
has been convicted of any crime or engaged in any conduct for which debarment
is mandated by 21 U.S.C. Section 335a(a) or any similar Legal Provision or authorized
by 21 U.S.C. Section 335a(b) or any similar Legal Provision.&#160; The Company has not employed any individual
or entity (and, to the Knowledge of the Company, has not used a contractor or
consultant) that has been debarred by the FDA (or subject to a similar sanction
by any foreign regulatory equivalent of the FDA) or that is the subject of an
FDA debarment investigation or proceeding (or similar proceeding of any foreign
regulatory equivalent of the FDA) in the conduct of the preclinical or clinical
studies of any Pharmaceutical Product.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(v) <u>Insurance</u>.&#160;&#160; Section 3.01(v) of the Company Disclosure
Schedule sets forth a complete and correct list of all material insurance
policies (including policies providing property, casualty, liability, workers
compensation, theft, bond and surety arrangements) to which the Company is a
party, named insured or otherwise the beneficiary of coverage, and describes
all self-insurance arrangements of the Company, if any.&#160; Each such insurance policy is in full force
and effect and the Company is not in violation of or in default under (nor
does, to the Knowledge of the Company, there exist any condition which upon the
passage of time or the giving of notice or both would cause such a violation of
or default under or give rise to a right of termination or modification under)
any such insurance policy, except for such violations or defaults that
individually </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=35,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=495799,FOLIO='30',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">31</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">or
in the aggregate have not had and would not reasonably be expected to have a
Company Material Adverse Effect.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section3_02_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
3.02.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Representations and Warranties of Parent and Sub.</u>&#160; Parent and Sub represent and warrant to the
Company as follows:</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;
<u>Organization, Standing and Corporate Power.</u>&#160; Each of Parent and Sub is a corporation duly
organized, validly existing and in good standing under the laws of the
jurisdiction in which it is incorporated and has all requisite corporate power
and corporate authority to carry on its business as now being conducted.&#160; Each of Parent and Sub is duly qualified or
licensed to do business and is in good standing in each jurisdiction in which
the nature of its business or the ownership, leasing or operation of its
properties makes such qualification or licensing necessary, except for those
jurisdictions in which the failure to be so qualified or licensed or to be in
good standing individually or in the aggregate has not had and would not
reasonably be expected to have a Parent Material Adverse Effect.&#160; Parent has made available to the Company
prior to the execution of this Agreement complete and correct copies of its
Articles of Association and the Certificate of Incorporation and By-laws of
Sub, in each case as amended to the date of this Agreement.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;
<u>Capital Structure.</u>&#160; (i)
&nbsp;At the close of business on March 18, 2002,
(A)&nbsp;198,000,000&nbsp;Parent Ordinary Shares were issued and outstanding,
all of which were validly issued, fully paid and nonassessable, (B)&nbsp;no
Parent Ordinary Shares were held by Parent in its treasury or by subsidiaries
of Parent, (C)&nbsp;no Parent Ordinary Shares were reserved for issuance upon
conversion of outstanding convertible bonds and option debenture bonds and
(D)&nbsp;less than 3,000,000 Parent Ordinary Shares were subject to outstanding
options to purchase Parent Ordinary Shares or Parent ADSs.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)&#160;
The authorized capital stock of Sub consists of 1,000 shares of common
stock, par value $.001 per share, all of which are validly issued, fully paid
and nonassessable and are owned by Parent free and clear of any Lien.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;
<u>Authority; Noncontravention.</u>&#160;
(i)&nbsp;Each of Parent and Sub has all requisite corporate power and
corporate </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=36,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=695193,FOLIO='31',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">authority
to enter into this Agreement and to consummate the transactions contemplated by
this Agreement.&#160; Parent has the
requisite corporate power and corporate authority to enter into the
Stockholders Agreement and to consummate the transactions contemplated by the
Stockholders Agreement.&#160; The execution
and delivery of this Agreement and the Stockholders Agreement by Parent and
Sub, as applicable, and the consummation by Parent and Sub, as applicable, of
the transactions contemplated by this Agreement and the Stockholders Agreement
have been duly authorized by all necessary corporate action on the respective
parts of Parent and Sub, as applicable, subject, in the case of the issuance by
Parent of Parent ADSs in connection with the Merger, to (A) obtaining the
requisite authorization (x) to repurchase Parent Ordinary Shares and (y) to
exclude any subscription rights of existing holders of Parent Ordinary Shares
by the affirmative vote of holders of not less than a majority of Parent
Ordinary Shares voting in person or by proxy (the &#147;Parent Shareholder
Approval&#148;) at a duly convened general meeting of the shareholders of Parent
(the &#147;Parent Shareholders&#146; Meeting&#148;), (B) the absence of a pending lawsuit,
filed by a holder of Parent Ordinary Shares with the requisite Governmental
Entity in the Federal Republic of Germany within the period prescribed therefor
in accordance with applicable law, relating to an objection of record of such
shareholder with respect to the authorization described in clause (A) above and
(C) completing such repurchase of Parent Ordinary Shares through a series of
transactions (the &#147;Parent Share Authorization&#148;).&#160; Other than the Parent Share Authorization, no other corporate
proceedings on the part of Parent or Sub, as applicable, are necessary to
authorize this Agreement or the Stockholders Agreement or to consummate the
transactions contemplated by this Agreement and the Stockholders
Agreement.&#160; Subject to obtaining the
Parent Share Authorization, the Parent Ordinary Shares represented by the
Parent ADSs to be issued pursuant to this Agreement shall have been duly
authorized and validly issued and shall be fully paid and nonassessable and
shall have been, on or prior to the Closing Date, duly and validly deposited
with the Depositary.&#160; Subject to
obtaining the Parent Share Authorization, the Parent ADSs to be issued pursuant
to the transactions contemplated by this Agreement shall, when issued, be duly
authorized, validly issued, fully paid and nonassessable and shall entitle the
holder thereof to all rights of a Holder (as defined in the Deposit Agreement).&#160; Each of this Agreement and the Stockholders
Agreement has been duly executed and delivered by Parent and Sub, as
applicable, and, assuming the </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=37,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=1031329,FOLIO='32',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">33</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">due
authorization, execution and delivery by each of the other parties thereto,
constitutes a legal, valid and binding obligation of Parent and Sub, as
applicable, enforceable against Parent and Sub, as applicable, in accordance
with its terms.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)&#160;
Subject to obtaining the Parent Share Authorization and to the making of
all notices or submissions to the requisite Governmental Entities in the
Federal Republic of Germany in connection with the Parent Share Authorization,
the execution and delivery of this Agreement and the Stockholders Agreement do
not, and the consummation of the Merger and the other transactions contemplated
by this Agreement and the Stockholders Agreement and compliance with the
provisions of this Agreement and the Stockholders Agreement will not, conflict
with, or result in any violation or breach of, or default (with or without
notice or lapse of time, or both) under, or give rise to a right of, or result
in, termination, cancelation or acceleration of any obligation or to the loss
of a benefit under, or result in the creation of any Lien in or upon any of the
properties or other assets of Parent or Sub under, or give rise to any
increased, additional, accelerated or guaranteed rights or entitlements under,
any provision of (A)&nbsp;the Articles of Association of Parent or the
Certificate of Incorporation or By-laws of Sub, (B)&nbsp;any loan or credit
agreement, bond, debenture, note, mortgage, indenture, lease or other contract,
agreement, obligation, commitment, arrangement, understanding, instrument,
permit, concession, franchise, license or similar authorization applicable to
Parent or Sub or any of their respective properties or other assets or
(C)&nbsp;subject to the governmental filings and other matters referred to in
Section 3.02(c)(iii), any (1)&nbsp;statute, law, ordinance, rule or regulation
or (2)&nbsp;order, writ, injunction, decree, judgment or stipulation, in each
case applicable to Parent or Sub or any of their respective properties or other
assets, other than, in the case of clauses&nbsp;(B) and (C), any such
conflicts, violations, breaches, defaults, rights, losses, Liens or entitlements
that individually or in the aggregate have not had and would not reasonably be
expected to (x) have a Parent Material Adverse Effect (y) impair the ability of
Parent to perform its obligations under this Agreement or (z) prevent or
materially delay the consummation of the transactions contemplated by this
Agreement or the Stockholders Agreement.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)&#160;
No consent, approval, order or authorization of, action by or in respect
of, or registration, declaration or </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=38,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=719228,FOLIO='33',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">34</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">filing
with, any Governmental Entity is required by or with respect to Parent or Sub
in connection with the execution and delivery of this Agreement and the
Stockholders Agreement or the consummation of the Merger or the other transactions
contemplated by this Agreement and the Stockholders Agreement, except for
(A)&nbsp;the filing of a premerger notification and report form by Parent under
the HSR Act, and any applicable filings and approvals under similar foreign
antitrust or competition laws and regulations, (B)&nbsp;the filing with the SEC
of (1)&nbsp;the Form&nbsp;F-4 and (2)&nbsp;such reports under
Section&nbsp;13(a), 13(d), 15(d) or 16(a) of the Exchange Act as may be
required in connection with this Agreement and the Stockholders Agreement and
the transactions contemplated by this Agreement and the Stockholders Agreement,
(C)&nbsp;the filing of the Certificate of Merger with the Secretary of State of
the State of Delaware and appropriate documents with the relevant authorities
of other jurisdictions in which Parent or Sub are qualified to do business and
such filings with Governmental Entities to satisfy the applicable requirements
of state securities or &#147;blue sky&#148; laws, (D) such filings with and approvals of
the New York Stock Exchange, Inc. (the &#147;NYSE&#148;) to permit the Parent ADSs
issuable to stockholders of the Company as contemplated by this Agreement to be
listed on the NYSE, (E) the making of all notices or submissions to, and the
obtaining of all registrations of, the requisite Governmental Entities in the Federal
Republic of Germany and the Frankfurt Stock Exchange in connection with the
Parent Share Authorization and (F)&nbsp;such other consents, approvals, orders,
authorizations, actions, registrations, declarations and filings the failure of
which to be obtained or made, individually or in the aggregate, has not had and
would not reasonably be expected to (x) have a Parent Material Adverse Effect,
(y) impair the ability of Parent to perform its obligations under this
Agreement or (z) prevent or materially delay the consummation of the
transactions contemplated by this Agreement or the Stockholders Agreement.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;
<u>Parent SEC Documents.</u>&#160;
Parent has filed or furnished, as applicable, all required reports,
schedules, forms, statements and other documents (including exhibits and all
other information incorporated therein) with the SEC required to be filed or
furnished by it since September 27, 2000 (collectively, the &#147;Parent SEC
Documents&#148;).&#160; As of their respective
dates, the Parent SEC Documents complied in all material respects with the
requirements of the Securities Act or the Exchange Act, as the case may be, and
the rules and regulations of the SEC promulgated thereunder applicable to such </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=39,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=1017887,FOLIO='34',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">35</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Parent
SEC Documents, and none of the Parent SEC Documents at the time it was filed
contained any untrue statement of a material fact or omitted to state a
material fact required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they were made,
not misleading.&#160; Except to the extent
that information contained in any Parent SEC Document has been revised or
superseded by a later-filed Parent SEC Document, none of the Parent SEC
Documents contains any untrue statement of a material fact or omits to state
any material fact required to be stated therein or necessary in order to make
the statements therein, in light of the circumstances under which they were
made, not misleading.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)&#160;
<u>Information Supplied.</u>&#160;
None of the information supplied or to be supplied by Parent or Sub
specifically for inclusion or incorporation by reference in (i)&nbsp;the
Form&nbsp;F-4 will, at the time the Form F-4 becomes effective under the
Securities Act, contain any untrue statement of a material fact or omit to
state any material fact required to be stated therein or necessary to make the
statements therein not misleading or (ii)&nbsp;the Proxy Statement will, at the
date it is first mailed to the Company&#146;s stockholders or at the time of the
Company Stockholders&#146; Meeting, contain any untrue statement of a material fact
or omit to state any material fact required to be stated therein or necessary
in order to make the statements therein, in light of the circumstances under
which they are made, not misleading.&#160;
The Form&nbsp;F-4 will comply as to form in all material respects with
the requirements of the Securities Act and the rules and regulations
promulgated thereunder.&#160; No representation
or warranty is made by Parent or Sub with respect to statements made or incorporated
by reference in the Form&nbsp;F-4 based on information supplied by the Company
specifically for inclusion or incorporation by reference in the Form&nbsp;F-4.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)&#160;
<u>Interim Operations of Sub.</u>&#160;
Sub was formed solely for the purpose of engaging in the transactions
contemplated by this Agreement, has engaged in no other business activities and
has conducted its operations only as contemplated by this Agreement.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)&#160;
<u>Tax Matters.</u>&#160; Neither
Parent, Sub nor any Affiliate of Parent has taken or agreed to take any action
or knows of any fact, agreement, plan or other circumstance that is reasonably
likely to (i) prevent the Merger from qualifying as a </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=40,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=302425,FOLIO='35',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">36</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">reorganization
within the meaning of Section&nbsp;368(a) of the Code or (ii) cause the
Eligible Company Stockholders who exchange Company Common Stock solely for
Parent ADSs pursuant to the Merger to recognize taxable gain with respect to
the Merger pursuant to Section 367(a) of the Code (except with respect to any cash
received in lieu of fractional Parent ADSs).</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h) <u>Absence of Certain Changes or Events</u>.&#160; Except for liabilities incurred in
connection with or expressly permitted by this Agreement and except as
disclosed in the Parent SEC Documents filed and publicly available prior to the
date of this Agreement, since December 31, 2001, there has not been&nbsp;any
Parent Material Adverse Change.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><a name="ArticleIv"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE
IV</font></a></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><a name="CovenantsRelatingToConductOfBusines"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Covenants Relating to Conduct of
Business</font></u></a></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section4_01_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
4.01.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Conduct of Business.</u>&#160;
(a)&nbsp;&nbsp;<u>Conduct of Business by the Company.</u>&#160; Except as set forth in Section&nbsp;4.01(a)
of the Company Disclosure Schedule, as otherwise expressly permitted by this
Agreement or as consented to in writing by Parent, such consent not to be
unreasonably withheld or delayed, during the period from the date of this
Agreement to the Effective Time, the Company shall carry on its business in the
ordinary course consistent with past practice (including in respect of research
and development activities and programs) and in compliance with all applicable laws
and regulations and, to the extent consistent therewith, use all commercially
reasonable efforts to preserve intact its current business organizations, keep
available the services of its current officers, employees and consultants and
preserve its relationships with customers, suppliers, licensors, licensees,
distributors and others having business dealings with it.&#160; Without limiting the generality of the
foregoing, during the period from the date of this Agreement to the Effective
Time, except as set forth in Section&nbsp;4.01(a) of the Company Disclosure
Schedule, as otherwise expressly permitted by this Agreement or as consented to
in writing by Parent, such consent not to be unreasonably withheld or delayed,
the Company shall not:</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i) (A)&nbsp;declare, set aside or
pay any dividends on, or make any other distributions (whether in cash, stock
or property), in respect of, any of its capital stock, </font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=41,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=172064,FOLIO='36',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">37</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(B)&nbsp;split, combine or reclassify any
of its capital stock or issue or authorize the issuance of any other securities
in respect of, in lieu of or in substitution for shares of its capital stock or
(C)&nbsp;purchase, redeem or otherwise acquire any shares of its capital stock
or any other securities thereof or any rights, warrants or options to acquire
any such shares or other securities;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii) issue, deliver, sell, grant,
pledge or otherwise encumber or subject to any Lien any shares of its capital
stock, any other voting securities or any securities convertible into, or any
rights, warrants or options to acquire, any such shares, voting securities or
convertible securities, or any &#147;phantom&#148; stock, &#147;phantom&#148; stock rights, stock
appreciation rights, stock options, restricted shares, stock based performance
units or any similar awards (other than the issuance of shares of Company
Common Stock (A)&nbsp;upon the exercise of Company Stock Options outstanding on
the date of this Agreement and (B)&nbsp;pursuant to the Company&#146;s Employee
Stock Purchase Plan, in each case in accordance with their terms on the date of
this Agreement);</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii) amend or propose to amend the
Company Certificate or the Company By-laws;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv) directly or indirectly acquire
by merging or consolidating with, or by purchasing assets of, or by any other
manner, any person or division, business or equity interest of any person,
except for purchases of materials or supplies or other routine purchases in the
ordinary course of business consistent with past practice;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(v) sell, lease, license, mortgage,
sell and leaseback or otherwise encumber or subject to any Lien or otherwise
dispose of any of its properties or other assets or any interests therein
(including securitizations);</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(vi) (A)&nbsp;incur any indebtedness
for borrowed money or guarantee any such indebtedness of another person, issue
or sell any debt securities or warrants or other rights to acquire any debt
securities of the Company, guarantee any debt securities of another person,
enter into any &#147;keep well&#148; or other agreement to maintain any financial
statement condition of another person or enter into any arrangement having the
economic effect of any of the </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=42,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=808303,FOLIO='37',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">38</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">foregoing, except for short-term borrowings
incurred in the ordinary course of business consistent with past practice,
(B)&nbsp;make any loans, advances or capital contributions to, or investments
in, any other person or (C)&nbsp;repay, redeem or otherwise retire, or make any
other payment in respect of, any indebtedness for borrowed money, other than as
required by its terms as in effect on the date of this Agreement;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(vii) make or agree to make any new
capital expenditure or expenditures;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(viii) (A) pay, discharge, settle or
satisfy any claims, liabilities or obligations (absolute, accrued, asserted or
unasserted, contingent or otherwise) or litigation (whether or not commenced
prior to the date of this Agreement), other than the payment, discharge,
settlement or satisfaction, in the ordinary course of business consistent with
past practice or in accordance with their terms, of liabilities disclosed,
reflected or reserved against in the most recent audited financial statements
(or the notes thereto) of the Company included in the Filed Company SEC
Documents (for amounts not in excess of the amounts so disclosed, reflected or
reserved) or incurred since the date of such financial statements in the
ordinary course of business consistent with past practice but in all cases
subject to clause&nbsp;(vi)(C) above, (B) waive or assign any claims or rights
of substantial value or (C)&nbsp;waive any benefits of, agree to modify in any
respect or terminate any confidentiality, standstill or similar agreement to
which the Company is a party or of which the Company is a beneficiary;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ix) modify or amend in any material
respect or terminate or take any action which would result in a breach of any
material contract or agreement to which the Company is a party or waive,
release or assign any material rights or claims thereunder; <u>provided</u>
that the Company shall not modify or amend in any respect or terminate or take
any action which would result in a breach of any contract relating to any
Intellectual Property Rights of the Company;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(x) enter into any contracts,
agreements, binding arrangements or understandings relating to the research,
development, distribution, supply, license, marketing or </font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=43,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=151697,FOLIO='38',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">39</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">manufacturing by third parties of the
Company&#146;s products or products licensed by the Company other than pursuant to
any such contracts, agreements, arrangements or understandings currently in
place (that have been disclosed in writing to Parent prior to the date of this
Agreement) in accordance with their terms as of the date of this Agreement;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(xi) except as required to comply
with applicable law, (A)&nbsp;establish, adopt, enter into, terminate or amend
in any material respect (1) any Benefit Plan (or any plan or arrangement which
would constitute a Benefit Plan if in effect as of the date of this Agreement)
or (2)&nbsp;any other agreement, plan or policy involving the Company and any
Participants, (B)&nbsp;increase in any manner the compensation, bonus or fringe
or other benefits of, or pay any bonus to, any Participant, (C)&nbsp;accrue or
pay any benefit or amount not required under any Benefit Plan or Benefit
Agreement, (D)&nbsp;accrue or provide any severance, change of control or
termination pay or benefits to any Participant or increase in any manner any
such pay or benefits, (E)&nbsp;enter into, renew, extend, amend or terminate
any Benefit Agreement or any agreement which would constitute a Benefit
Agreement if in effect on the date of this Agreement, (F)&nbsp;grant any awards
under any Benefit Plan (including the grant of stock options, &#147;phantom&#148; stock,
stock appreciation rights, &#147;phantom&#148; stock rights, stock based or stock related
awards, performance units or restricted stock or the removal of existing
restrictions in any Benefit Plans or agreements or awards made thereunder),
(G)&nbsp;amend or modify any Company Stock Option, (H)&nbsp;take any action to
fund or in any other way secure the payment of compensation or benefits under
any Benefit Plan or Benefit Agreement other than as provided in such Benefit
Plan or Benefit Agreement in accordance with their respective terms as of the
date of this Agreement, provided any such provision has been identified in
Section 4.01(a)(xi)(H) of the Company Disclosure Schedule, (I)&nbsp;take any
action to accelerate the vesting of payment of any compensation or benefit
under any Benefit Plan or Benefit Agreement or (J)&nbsp;materially change any
actuarial or other assumption used to calculate funding obligations with
respect to any Benefit Plan or change the manner in which contributions to any
Benefit Plan are made or the basis on which such contributions are determined;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=44,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=449078,FOLIO='39',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">40</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(xii) enter into any agreement of a
nature that would be required to be filed as an exhibit to Form 10-K under the
Exchange Act;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(xiii) form any subsidiary of the
Company;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(xiv) revalue any material assets of
the Company or, except as required by GAAP, make any change in accounting
methods, principles or practices;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(xv) call or hold any meeting of
stockholders of the Company other than in connection with the election of
members of the Board of Directors of the Company or other routine matters in
the ordinary course of business consistent with past practice or for the
purpose of the adoption of this Agreement and the approval of the Merger and
the other transactions contemplated by this Agreement; or</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(xvi) authorize any of, or commit,
propose or agree to take any of, the foregoing actions.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&nbsp; <u>Other Actions.</u>&#160; Except as may be expressly permitted by this
Agreement, the Company, Parent and Sub shall not voluntarily take any action
that would, or that could reasonably be expected to, result in (i)&nbsp;any of
the representations and warranties of such party set forth in this Agreement
that are qualified by materiality becoming untrue at the Effective Time,
(ii)&nbsp;any of such representations and warranties that are not so qualified
becoming untrue in any material respect at the Effective Time or (iii)&nbsp;any
of the conditions to the Merger set forth in Article&nbsp;VI not being
satisfied.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;
<u>Advice of Changes; Filings.</u>&#160;
The Company and Parent shall promptly advise the other party orally and
in writing of (i)&nbsp;any representation or warranty made by it (and, in the
case of Parent, made by Sub) contained in this Agreement that is qualified as
to materiality becoming untrue or inaccurate in any respect or any such
representation or warranty that is not so qualified becoming untrue or
inaccurate in any material respect, (ii)&nbsp;the failure of it (and, in the
case of Parent, of Sub) to comply with or satisfy in any material respect any
covenant, condition or agreement to be complied with or satisfied by it under this
Agreement and (iii)&nbsp;any change or </font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=45,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=282049,FOLIO='40',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">41</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">event
having, or which could reasonably be expected to have, a material adverse
effect on the ability of the conditions set forth in Article&nbsp;VI to be
satisfied; <u>provided</u>, <u>however</u>, that no such notification shall
affect the representations, warranties, covenants or agreements of the parties
(or remedies with respect thereto) or the conditions to the obligations of the
parties under this Agreement.&#160; The
Company and Parent shall promptly provide the other copies of all filings made
by such party with any Governmental Entity in connection with this Agreement
and the transactions contemplated by this Agreement, other than the portions of
such filings that include confidential information not directly related to the
transactions contemplated by this Agreement.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;
<u>Certain Tax Matters.</u>&#160;
During the period from the date of this Agreement to the Effective Time,
the Company shall (i) timely file all tax returns (&#147;Post-Signing Returns&#148;)
required to be filed by it, (ii) timely pay all taxes due and payable in
respect of such Post-Signing Returns that are so filed, (iii)&nbsp;make a
provision in the books and records and financial statements of any such entity
in accordance with past practice for all taxes payable by such entity for which
no Post-Signing Return is due prior to the Effective Time, (iv)&nbsp;not make
any material tax election or settle or compromise any material tax liability,
other than in connection with currently pending proceedings or other than in
the ordinary course of business and (v)&nbsp;cause all existing tax sharing
agreements and similar agreements to which the Company is a party to be
terminated as of the Closing Date so that after such date the Company shall
have no further rights or liabilities thereunder.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section4_02_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
4.02.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>No Solicitation.</u>&#160;
(a)&nbsp;&nbsp;From and after the date of this Agreement, the Company
shall not, nor shall it authorize or permit any of its directors, officers or
other employees or any investment banker, financial advisor, attorney,
accountant or other advisor, agent or representative retained by it
(collectively, the &#147;Representatives&#148;) to, directly or indirectly through
another person, (i)&nbsp;solicit, initiate or encourage (including by way of
furnishing information), or take any other action designed to, or which could
reasonably be expected to, facilitate, any inquiries or the making of any
proposal that constitutes or could reasonably be expected to lead to, a
Takeover Proposal or (ii)&nbsp;participate in any discussions or negotiations
regarding any Takeover Proposal, in each case other than a Takeover Proposal
made by Parent; </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=46,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=345372,FOLIO='41',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">42</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">provided</font></u><font size="2" style="font-size:10.0pt;">,
<u>however</u>, that at any time prior to obtaining the Company Stockholder
Approval, the Board of Directors of the Company may, in response to a bona fide
written Takeover Proposal that the Board of Directors of the Company determines
in good faith constitutes or is reasonably likely to lead to a Superior
Proposal (as defined below), and which was unsolicited and did not otherwise
result from a breach of this Section 4.02, and subject to compliance with
Section 4.02 (c) and (d), (x) furnish information with respect to the Company
to the person making such Takeover Proposal (and its representatives) pursuant
to a customary confidentiality agreement (which confidentiality agreement
contains terms that are in no respect less favorable to the Company than the
terms of the Confidentiality Agreement (as defined in Section 5.04)); <u>provided</u>
that all such information is provided on a prior or substantially concurrent
basis to Parent, and (y) participate in discussions or negotiations with the
person making such Takeover Proposal (and its representatives) regarding such
Takeover Proposal.&#160; Without limiting the
foregoing, it is agreed that any violation of the restrictions set forth in the
first sentence of this Section 4.02(a) by any Representative of the Company,
whether or not such person is purporting to act on behalf of the Company or
otherwise, shall be a breach of this Section 4.02(a) by the Company.&#160; As of the date of this Agreement, the
Company shall have, and shall have caused each of its Representatives to have,
(i)&nbsp;terminated all discussions or negotiations with all third parties
regarding any Takeover Proposal and (ii)&nbsp;requested the prompt return or
destruction of all confidential information relating to the Company previously
furnished to any such third parties.&#160;
For purposes of this Agreement, &#147;Takeover Proposal&#148; means any bona fide
inquiry, proposal or offer from any person relating to, or that could
reasonably be expected to lead to, any direct or indirect acquisition or
purchase, in one transaction or a series of transactions, of a business that
constitutes 20% or more of the net revenues, net income or the assets of the
Company, or 20% or more of any class of equity securities of the Company, any
tender offer or exchange offer that if consummated would result in any person
beneficially owning 20% or more of any class of equity securities of the
Company, or any merger, consolidation, business combination, recapitalization,
liquidation, dissolution, joint venture, binding share exchange or similar
transaction involving the Company pursuant to which any third party or the
shareholders of any third party would own 20% or more of the Company or any
resulting parent company of the Company, or any direct or </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=47,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=183745,FOLIO='42',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">43</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">indirect
acquisition, purchase or transfer, in one transaction or a series of transactions,
of any rights of the Company in or to the product[s] known as Ad5FGF-4 and any
related Intellectual Property Rights or other assets or components of Ad5FGF-4,
other than the transactions contemplated by this Agreement or the Stockholders
Agreement.&#160; For purposes of this
Agreement, &#147;Superior Proposal&#148; means any bona fide offer not solicited by the
Company after the date of this Agreement made by a third party that if
consummated would result in such third party (or its shareholders) owning, directly
or indirectly, more than 35% of the shares of Company Common Stock then
outstanding (or of the surviving entity in a merger or the direct or indirect
parent of the surviving entity in a merger) or all or substantially all the
assets of the Company and otherwise on terms which the Board of Directors of
the Company determines in good faith (based on the advice of a financial
advisor of nationally recognized reputation), taking into account such factors
deemed appropriate by the Board of Directors of the Company, to be reasonably
likely to obtain stockholder and other required approvals on a timely basis and
to provide consideration to the holders of Company Common Stock with a greater
value than the consideration payable in the Merger, taking into account any
changes to the terms of this Agreement proposed by Parent in response to such
Superior Proposal or otherwise.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;
Neither the Board of Directors of the Company nor any committee thereof
shall (i) withdraw (or modify in a manner adverse to Parent or Sub) or propose
publicly to withdraw (or modify in a manner adverse to Parent or Sub) the
recommendation or declaration of advisability by the Board of Directors of the
Company or any such committee of this Agreement or the Merger, or recommend, or
propose publicly to recommend, the approval or adoption of any Takeover
Proposal (other than a Takeover Proposal made by Parent) (each such action
being referred to herein as an &#147;Adverse Recommendation&#148;), unless the Board of
Directors of the Company determines in good faith, based on such factors deemed
appropriate by it, after consulting with outside counsel, that the failure to
take such action would be reasonably likely to result in a breach of its
fiduciary duties under applicable law, (ii) adopt or approve, or propose
publicly to adopt or approve, any Takeover Proposal (other than a Takeover
Proposal made by Parent), or withdraw its approval of the Merger or propose
publicly to withdraw its approval of the Merger, (iii) cause or permit the
Company to execute or enter </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=48,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=333325,FOLIO='43',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">44</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">into
any letter of intent, memorandum of understanding, agreement in principle,
merger agreement, acquisition agreement, option agreement, joint venture
agreement, license agreement, partnership agreement or other similar agreement
(each, an &#147;Acquisition Agreement&#148;) constituting or related to, or which is
intended to or could reasonably be expected to lead to, any Takeover Proposal
(other than a confidentiality agreement referred to in Section 4.02(a)) or (iv)
agree or resolve to take any of the actions prohibited by clauses (i), (ii) or
(iii) of this sentence.&#160; Notwithstanding
anything in this Section 4.02 to the contrary, at any time prior to obtaining
the Company Stockholder Approval, the Board of Directors of the Company may, in
response to a Superior Proposal that was unsolicited and that did not otherwise
result from a breach of Section 4.02(a), cause the Company to terminate this
Agreement pursuant to Section 7.01(f) and concurrently enter into an
Acquisition Agreement; provided however, that the Company shall not terminate
this Agreement pursuant to Section 7.01(f), and any purported termination
pursuant to Section 7.01(f) shall be void and of no force or effect, unless the
Company shall have complied with the provisions of this Section 4.02, including
the notification provisions in this Section 4.02, and with all applicable
requirements of Section 5.08(b) (including the payment of the Termination Fee
(as defined in Section 5.08(b)) prior to or concurrently with such
termination); and provided further, however, that the Company shall not
exercise its rights to terminate this Agreement pursuant to Section 7.01(f)
until after the fifth Business Day following Parent&#146;s receipt of written notice
(a &#147;Notice of Superior Proposal&#148;) from the Company advising Parent that the
Board of Directors of the Company has received a Superior Proposal, identifying
the person making such Superior Proposal and stating that the Board of
Directors of the Company intends to exercise its right to terminate this
Agreement pursuant to Section 7.01(f) (it being understood and agreed that,
prior to such termination taking effect, any amendment to the price or any
other material term of a Superior Proposal shall require a new Notice of
Superior Proposal and a new five Business Day period).</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;
In addition to the obligations of the Company set forth in Sections
4.02(a) and 4.02(b), the Company shall immediately advise Parent orally and in
writing of any request for information that the Company reasonably believes
could lead to or contemplates a Takeover Proposal or of any Takeover Proposal,
or any inquiry the Company reasonably believes could </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=49,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=573253,FOLIO='44',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">45</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">lead
to any Takeover Proposal, the terms and conditions of such request, Takeover
Proposal or inquiry (including any subsequent amendment or other modification
to such terms and conditions) and the identity of the person making such
request, Takeover Proposal or inquiry.&#160;
The Company shall keep Parent fully informed of the status and details
(including amendments or proposed amendments) of any such request, Takeover
Proposal or inquiry and shall provide to Parent as soon as practicable after
receipt or delivery thereof with copies of all correspondence and other written
material sent or provided to the Company from any third party in connection
with any Takeover Proposal or sent or provided by the Company to any third
party in connection with any Takeover Proposal.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;
Nothing contained in this Section&nbsp;4.02 shall prohibit the Company
from (i) taking and disclosing to its stockholders a position contemplated by
Rules 14d-9 and 14e-2(a) promulgated under the Exchange Act or (ii) making any
required disclosure to the Company&#146;s stockholders if, in the good faith
judgment of the Board of Directors of the Company, after consultation with
outside counsel, failure to so disclose would be inconsistent with its
obligations under applicable law; <u>provided</u>, <u>however</u>, that in no
event shall the Company or its Board of Directors or any committee thereof
take, or agree to resolve to take, any action prohibited by Section 4.02(b)(i)
or 4.02(b)(ii).</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><a name="ArticleV"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE
V</font></a></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><a name="AdditionalAgreements"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Additional Agreements</font></u></a></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section5_01_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
5.01.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Preparation of the Form&nbsp;F-4 and the</u>  <u>Proxy Statement;
Company Stockholders&#146; Meeting.</u>&#160;
(a)&nbsp;&nbsp;As soon as practicable following the date of this
Agreement, the Company and Parent shall prepare and the Company shall file with
the SEC the Proxy Statement and Parent shall file with the SEC the Form&nbsp;F-4,
in which the Proxy Statement shall be included as a prospectus.&#160; Each of the Company and Parent shall use its
commercially reasonable efforts to have the Form&nbsp;F-4 declared effective
under the Securities Act as promptly as practicable after such filing.&#160; The Company shall use its commercially
reasonable efforts to cause the Proxy Statement to be mailed to the Company&#146;s
stockholders as promptly as practicable after the Form&nbsp;F-4 is declared
effective under the Securities Act.&#160;
Parent </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=50,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=478136,FOLIO='45',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">46</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">shall
also take any action (other than qualifying to do business in any jurisdiction
in which it is not now so qualified or filing a general consent to service of
process) required to be taken under any applicable state securities laws in
connection with the issuance of Parent ADSs in the Merger, and the Company
shall furnish all information concerning the Company and the holders of Company
Common Stock as may be reasonably requested in connection with any such action.&#160; No filing of, or amendment or supplement to,
or correspondence to the SEC or its staff with respect to, the Form&nbsp;F-4
shall be made by Parent, and no filing of, or amendment or supplement to, or
correspondence to the SEC or its staff with respect to, the Proxy Statement shall
be made by the Company, in each case without providing the other party the
opportunity to review and comment thereon.&#160;
If at any time prior to the Effective Time any information relating to
the Company or Parent, or any of their respective Affiliates, directors or
officers, should be discovered by the Company or Parent which should be set
forth in an amendment or supplement to either the Form&nbsp;F-4 or the Proxy
Statement, so that (i) the Form F-4 would not include any misstatement of a
material fact or omit to state any material fact necessary to make the
statements therein not misleading or (ii) the Proxy Statement would not include
any misstatement of a material fact or omit to state any material fact
necessary to make the statements therein, in light of the circumstances under
which they were made, not misleading, as applicable, the party which discovers
such information shall promptly notify the other parties hereto and an
appropriate amendment or supplement describing such information shall be promptly
filed with the SEC and, to the extent required by law, disseminated to the
stockholders of the Company.&#160; The
parties shall notify each other promptly of the receipt of any comments from
the SEC or its staff and of any request by the SEC or its staff for amendments
or supplements to the Proxy Statement or the Form F-4 or for additional
information and shall supply each other with copies of all correspondence
between it or any of its Representatives, on the one hand, and the SEC or its
staff on the other hand, with respect to the Proxy Statement, the Form F-4 or
the Merger.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;
The Company (i)&nbsp;shall, as soon as practicable following the date of
this Agreement, establish a record date (which shall be as soon as practicable
following the date of this Agreement) for, duly call, give notice of, convene
and hold a meeting of its stockholders (the &#147;Company Stockholders&#146; Meeting&#148;)
solely for the purpose of obtaining the Company </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=51,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=10175,FOLIO='46',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">47</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Stockholder
Approval and (ii)&nbsp;except as expressly permitted pursuant to
Section&nbsp;4.02(b), shall, through its Board of Directors, recommend to its
stockholders the approval and adoption of this Agreement, the Merger and the
other transactions contemplated by this Agreement and use commercially
reasonable efforts to solicit the Company Stockholder Approval.&#160; The Company agrees that its obligations
pursuant to this Section&nbsp;5.01(b) shall not be affected by the
commencement, public proposal, public disclosure or communication to the
Company or any other person of any Takeover Proposal.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section5_02_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
5.02.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Letters of the Company&#146;s Accountants.</u>&#160; The Company shall use its commercially reasonable efforts to
cause to be delivered to Parent two letters from Ernst &amp; Young LLP, the
Company&#146;s independent public accountants, one dated a date within two business
days before the date on which the Form&nbsp;F-4 shall become effective and one
dated a date within two business days before the Closing Date, each addressed
to Parent, in form and substance reasonably satisfactory to Parent and
customary in scope and substance for comfort letters delivered by independent
public accountants in connection with registration statements similar to the
Form&nbsp;F-4.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section5_03_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
5.03.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Letters of Parent&#146;s Accountants.</u>&#160;
Parent shall use its commercially reasonable efforts to cause
to&nbsp;be&nbsp;delivered&nbsp;to the Company two letters from each of BDO
Deutsche Warentreuhand Aktiengessellschaft and BDO International GmbH, Parent&#146;s
independent public accountants, one from each dated a date within two business
days before the date on which the Form&nbsp;F-4 shall become effective and one
from each dated a date within two business days before the Closing Date, each
addressed to the Company, in form and substance reasonably satisfactory to the
Company and customary in scope and substance for comfort letters delivered by
independent public accountants in connection with registration statements
similar to the Form&nbsp;F-4.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section5_04_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
5.04.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Access to Information; Confidentiality.</u>&#160; The Company shall afford to Parent, and to Parent&#146;s officers,
employees, accountants, counsel, financial advisors and other representatives,
reasonable access during normal business hours during the period prior to the
Effective Time or the termination of this Agreement to all its properties, books,
contracts, commitments, personnel and records and, during such period, the
Company shall furnish promptly to Parent (a)&nbsp;a copy of each </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=52,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=478748,FOLIO='47',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">48</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">report,
schedule, registration statement and other document filed by it during such
period pursuant to the requirements of Federal or state securities laws and
(b)&nbsp;all other information concerning its business, properties and
personnel as Parent may reasonably request.&#160;
Except for disclosures expressly permitted by the terms of the
Confidential Disclosure Agreement dated as of October&nbsp;26, 2001, between
Parent and the Company (as it may be amended from time to time, the
&#147;Confidentiality Agreement&#148;), Parent shall hold, and shall cause its officers,
employees, accountants, counsel, financial advisors and other representatives
and controlled Affiliates to hold, all information received from the Company,
directly or indirectly, in confidence in accordance with the Confidentiality
Agreement.&#160; Neither Parent nor the Company
shall be required to provide access to or disclose information where such
access or disclosure would contravene any applicable law, rule, regulation,
order or decree or would, with respect to any pending matter, result in a
waiver of attorney-client privilege or the protections afforded attorney
work-product.&#160; Parent and the Company
shall use commercially reasonable efforts to obtain from third parties any
consents or waivers of confidentiality restrictions with respect to any
information being provided by it.&#160; No
investigation pursuant to this Section&nbsp;5.04 or information provided or
received by any party hereto after the date hereof pursuant to this Agreement
shall affect any of the representations or warranties of the parties hereto
contained in this Agreement or the conditions hereunder to the obligations of
the parties hereto.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section5_05_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
5.05.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Commercially Reasonable Efforts.</u>&#160;
Upon the terms and subject to the conditions set forth in this
Agreement, each of the parties hereto agrees to use its commercially reasonable
efforts to take, or cause to be taken, all actions, and to do, or cause to be
done, and to assist and cooperate with the other parties in doing, all things
necessary, proper or advisable to consummate and make effective, in the most
expeditious manner practicable, the Merger and the other transactions
contemplated by this Agreement and the Stockholders Agreement, including using
commercially reasonable efforts to accomplish the following:&#160; (a)&nbsp;the taking of all reasonable acts
necessary to cause the conditions to Closing to be satisfied as promptly as
practicable, (b)&nbsp;the obtaining of all necessary actions or nonactions,
waivers, consents and approvals from Governmental Entities and the making of
all necessary registrations and filings (including filings with Governmental </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=53,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=912906,FOLIO='48',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">49</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Entities,
if any) and the taking of all steps as may be necessary to obtain an approval
or waiver from, or to avoid any suit, claim, action or proceeding by any
Governmental Entity, (c)&nbsp;the obtaining of all necessary consents,
approvals or waivers from third parties, (d)&nbsp;the defending of any lawsuits
or other legal proceedings, whether judicial or administrative, challenging
this Agreement or the Stockholders Agreement, or the consummation of the Merger
or the other transactions contemplated by, and to carry out the purposes of,
this Agreement and the Stockholders Agreement, including seeking to have any
stay or temporary restraining order entered by any court or other Governmental
Entity vacated or reversed and (e)&nbsp;the execution and delivery of any
additional instruments necessary to consummate the transactions contemplated
by, and to fully carry out the purposes of, this Agreement and the Stockholders
Agreement.&#160; In connection with and
without limiting the foregoing, the Company and its Board of Directors shall
(a)&nbsp;use its commercially reasonable efforts to ensure that no state
takeover statute or similar statute or regulation is or becomes applicable to
this Agreement, the Stockholders Agreement, the Merger or any of the other
transactions contemplated by this Agreement or the Stockholders Agreement and
(b)&nbsp;if any state takeover statute or similar statute becomes applicable to
this Agreement, the Stockholders Agreement, the Merger or any other
transactions contemplated by this Agreement or the Stockholders Agreement, use
its commercially reasonable efforts to ensure that the Merger and the other
transactions contemplated by this Agreement and the Stockholders Agreement may
be consummated as promptly as practicable on the terms contemplated by this
Agreement and the Stockholders Agreement and otherwise to minimize the effect
of such statute or regulation on this Agreement, the Stockholders Agreement,
the Merger and the other transactions contemplated by this Agreement and the
Stockholders Agreement.&#160; Nothing in this
Agreement shall be deemed to require Parent to agree to, or proffer to, divest
or hold separate any assets or any portion of any business of Parent or its
subsidiaries or the Company.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section5_06_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
5.06.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Treatment of Equity Awards.</u>&#160;
(a)&#160; Neither Parent nor the
Surviving Corporation shall assume any Company Stock Options in connection with
the transactions contemplated by this Agreement.&#160; Accordingly, pursuant to the terms of the Company&#146;s 1995 Stock
Option Plan and 1998 Stock Incentive Plan (collectively, and together with the
Company&#146;s Employee Stock Purchase Plan, the &#147;Company Stock Plans&#148;), (i)</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=54,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=675203,FOLIO='49',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">50</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">each
outstanding Company Stock Option (other than those granted under the Company&#146;s
Employee Stock Purchase Plan) shall automatically accelerate so that each such
Company Stock Option shall, immediately prior to the Effective Time, become
fully exercisable for all of the shares of Company Common Stock at the time
subject to such Company Stock Option and may be exercised by the holder thereof
for any or all of such shares as fully-vested shares of Company Common Stock
and (ii) upon the Effective Time, all outstanding Company Stock Options, to the
extent not exercised prior to the Effective Time, shall terminate and shall
cease to be outstanding.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;
As soon as practicable following the date of this Agreement, the Company
shall (i)&nbsp;terminate, effective at the Effective Time, the Company Stock
Plans and (ii)&nbsp;provide that there shall not be any additional purchase
interval, as defined in the Company&#146;s Employee Stock Purchase Plan (each, a
&#147;Purchase Interval&#148;), commencing following the date of this Agreement under the
Company&#146;s Employee Stock Purchase Plan.&#160;
If the Effective Time occurs on or before July 31, 2002, then, with
respect to the Purchase Interval in effect as of the date of this Agreement,
immediately prior to the Effective Time each then outstanding purchase right under
the Company&#146;s Employee Stock Purchase Plan shall automatically be exercised, by
applying the payroll deductions of each current participant in the Company&#146;s
Employee Stock Purchase Plan for such Purchase Interval to the purchase of
whole shares of Company Common Stock (subject to the provisions of the
Company&#146;s Employee Stock Purchase Plan regarding the number of shares
purchasable per participant) at a purchase price per share equal to 85% of the
lower of (x) the fair market value per share of Company Common Stock on such
participant&#146;s Entry Date (as defined in the Company&#146;s Employee Stock Purchase
Plan) into the current offering period under the Company&#146;s Employee Stock
Purchase Plan and (y) the fair market value per share of Company Common Stock
immediately prior to the Effective Time.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section5_07_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
5.07.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Indemnification, Exculpation and Insurance.</u>&#160; (a)&nbsp;&nbsp;All rights to indemnification
and exculpation (including any rights related to the advancement of expenses)
from liabilities for acts or omissions occurring at or prior to the Effective
Time now existing in favor of the current or former directors or officers of
the Company as provided in the Company Certificate, the Company By-laws or any
indemnification agreement between such directors or officers and the Company
(in </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=55,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=597045,FOLIO='50',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">51</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">each
case, as in effect on the date of this Agreement) shall be assumed by the
Surviving Corporation in the Merger, without further action, as of the
Effective Time and shall survive the Merger and shall continue in full force
and effect in accordance with their terms.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&nbsp;&nbsp;In the event that the
Surviving Corporation or any of its successors or assigns (i)&nbsp;consolidates
with or merges into any other person and is not the continuing or surviving
corporation or entity of such consolidation or merger or (ii)&nbsp;transfers or
conveys all or substantially all its properties and other assets to any person,
then, and in each such case, Parent shall cause proper provision to be made so
that the successors and assigns of the Surviving Corporation assume the
obligations set forth in this Section&nbsp;5.07.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&nbsp;&nbsp;For a period of six years
from and after the Effective Time, Parent shall maintain in effect the
Company&#146;s current directors&#146; and officers&#146; liability insurance covering acts or
omissions occurring at or prior to the Effective Time, covering each person
currently covered by the Company&#146;s directors&#146; and officers&#146; liability insurance
policy (a complete and correct copy of which has been heretofore delivered to
Parent), on terms with respect to such coverage and amount no less favorable
than those of such policy in effect on the date of this Agreement; <u>provided</u>,
<u>however</u>, that Parent may substitute therefor policies of Parent or its
subsidiaries containing terms with respect to coverage and amount no less
favorable in any material respect to such directors and officers; <u>provided
further</u>, <u>however</u>, that in satisfying its obligation under this
Section 5.07(c) Parent shall not be obligated to pay aggregate premiums for
insurance under this Section&nbsp;5.07(c) in excess of 150% of the amount of
the aggregate premiums paid by the Company in calendar year 2001 for such
purpose (which calendar year 2001 aggregate premiums the Company hereby
represent and warrant to be $222,000); it being understood and agreed that
Parent shall nevertheless be obligated to provide such coverage as may be
obtained for such 150% amount.&#160;
Notwithstanding anything in this Section 5.07(c) to the contrary,
Parent&#146;s obligation to provide directors&#146; and officers&#146; liability insurance
coverage under this Section 5.07(c) shall cease immediately upon such time, if
any, as Parent shall have assumed the obligations of the Surviving Corporation
under Section 5.07(a), regardless of whether any such time occurs within six
years from and after the Effective Time.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=56,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=846784,FOLIO='51',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">52</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&nbsp;&nbsp;The provisions of this
Section 5.07 (i) are intended to be for the benefit of, and shall be
enforceable by, each indemnified party, his or her heirs and his or her
representatives and (ii)&nbsp;are in addition to, and not in substitution for,
any other rights to indemnification or contribution that any such person may
have by contract or otherwise.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section5_08_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
5.08.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Fees and Expenses.</u>&#160;
(a)&nbsp;&nbsp;Except as provided in Section 5.08(b) and
Section&nbsp;5.16, all fees and expenses incurred in connection with this
Agreement, the Stockholders Agreement, the Merger and the other transactions
contemplated by this Agreement and the Stockholders Agreement shall be paid by
the party incurring such fees or expenses, whether or not the Merger is
consummated, except that each of Parent and the Company shall bear and pay
one-half of (i)&nbsp;the costs and expenses incurred in connection with filing,
printing and mailing the Proxy Statement and the Form&nbsp;F-4 (including SEC
filing fees) and (ii)&nbsp;the filing fees for the premerger notification and
report forms under the HSR Act and any similar foreign antitrust or competition
laws.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;
In the event that (i)&nbsp;(A) a Takeover Proposal shall have been made
to the Company or shall have been made directly to the stockholders of the
Company generally or shall have otherwise become publicly known or any person
shall have publicly announced an intention (whether or not conditional and
whether or not withdrawn) to make a Takeover Proposal, (B) thereafter this
Agreement is terminated by either Parent or the Company pursuant to Section
7.01(b)(i) (but only if the Company Stockholders&#146; Meeting has not been held by
the date that is five Business Days prior to the date of such termination) or
Section 7.01(b)(iii) and (C) within 15 months after such termination, the
Company enters into any Acquisition Agreement with respect to, or consummates,
any Takeover Proposal (solely for purposes of this Section 5.08(b)(i)(C), the
term &#147;Takeover Proposal&#148; shall have the meaning set forth in the definition of
Takeover Proposal contained in Section 4.02(a) except that all references to
20% shall be deemed references to 40%), (ii) this Agreement is terminated by the
Company pursuant to Section 7.01(f) or (iii) this Agreement is terminated by
Parent pursuant to Section 7.01(e), then the Company shall pay to Parent a fee
equal to $7.0 million (the &#147;Termination Fee&#148;) by wire transfer of same day
funds to an account designated by Parent (x) in the case of </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=57,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=783138,FOLIO='52',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">53</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">a
termination by the Company pursuant to Section 7.01(f), concurrently with such
termination, (y) in the case of a termination by Parent pursuant to Section
7.01(e), within two Business Days after such termination and (z) in the case of
a payment as a result of any event referred to in Section 5.08(b)(i)(C), upon
the first to occur of such events.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&nbsp;&nbsp;The Company acknowledges and
agrees that the agreements contained in Section&nbsp;5.08(b) are an integral
part of the transactions contemplated by this Agreement, and that, without
these agreements, Parent would not enter into this Agreement; accordingly, if
the Company fails promptly to pay the amount due pursuant to Section&nbsp;5.08(b),
and, in order to obtain such payment, Parent commences a suit that results in a
judgment against the Company for the Termination Fee, the Company shall pay to
Parent its reasonable costs and expenses (including attorneys&#146; fees and expenses)
in connection with such suit, together with interest on the amount of the
Termination Fee from the date such payment was required to be made until the
date of payment on the amount of the Termination Fee at the prime rate of
Citibank, N.A. in effect on the date such payment was required to be made.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section5_09_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
5.09.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Public Announcements.</u>&#160;
Promptly after the date of this Agreement, Parent and Company shall
develop a joint communications plan and each party hereto shall use
commercially reasonable efforts to ensure that all press releases and other
public statements with respect to the transactions contemplated by this
Agreement, including the Merger, and the Stockholders Agreement shall be
consistent with such joint communications plan.&#160; Parent and the Company shall consult with each other before
issuing any press release or otherwise making any written public statement with
respect to the transactions contemplated by this Agreement, including the
Merger, and the Stockholders Agreement and shall not issue any such press
release or make any such written public statement prior to such consultation,
except as either party may determine is required by applicable law or by
obligations pursuant to any listing agreement with any national securities
exchange or national trading system.&#160;
The parties agree that the initial press release to be issued with
respect to the transactions contemplated by this Agreement and the Stockholders
Agreement shall be in the form heretofore agreed to by the parties.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=58,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=813972,FOLIO='53',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">54</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section5_10_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
5.10.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Affiliates.</u>&#160; The Company
shall deliver to Parent at least 30&nbsp;days prior to the Closing Date a
letter identifying all persons who are, at the time this Agreement is submitted
for adoption by the stockholders of the Company, &#147;affiliates&#148; of the Company
for purposes of Rule&nbsp;145 promulgated under the Securities Act and other
applicable SEC rules and regulations.&#160;
The Company shall use its commercially reasonable efforts to cause each
such person to deliver to Parent at least 20&nbsp;days prior to the Closing
Date a written agreement substantially in the form attached as Exhibit&nbsp;B
hereto.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section5_11_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
5.11.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Stock Exchange Listing.</u>&#160;
Parent shall use its commercially reasonable efforts to cause the Parent
ADSs to be issued in the Merger to be approved for listing on the NYSE, subject
to official notice of issuance, prior to the Closing Date.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section5_12_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION&nbsp;5.12.</font></a><font size="2" style="font-size:10.0pt;">&#160; <u>Tax Treatment.</u>
Each of Parent and the Company shall use commercially reasonable efforts to
permit the Company to obtain the opinion of counsel referred to in Section
6.03(c) and shall not take or fail to take actions that could reasonably be
expected to prevent the receipt of such tax opinion.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section5_13_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION&nbsp;5.13.</font></a><font size="2" style="font-size:10.0pt;">&#160; <u>Stockholder
Litigation.</u>&#160; The Company shall give
Parent the opportunity to participate in the defense or settlement of any
stockholder litigation against the Company and/or its directors relating to the
transactions contemplated by this Agreement or the Stockholders Agreement, and
no such settlement shall be agreed to without Parent&#146;s prior written consent.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section5_14_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
5.14.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Rights Agreement.</u>&#160; The
Board of Directors of the Company shall take all further action (in addition to
that referred to in Section&nbsp;3.01(t)) requested by Parent in order to
render the rights (the &#147;Rights&#148;) issued pursuant to the Rights Agreement to
purchase Series&nbsp;A Junior Participating Preferred Stock of the Company,
inapplicable to the Merger and the other transactions contemplated by this
Agreement and the Stockholders Agreement.&#160;
Except as provided above with respect to the Merger and the other
transactions contemplated by this Agreement and the Stockholders Agreement, the
Board of Directors of the Company shall not, without the prior written consent
of Parent, (a)&nbsp;amend the Rights Agreement or (b)&nbsp;take any action with
respect to, or make any </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=59,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=35407,FOLIO='54',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">55</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">determination
under, the Rights Agreement, including a redemption of the Rights or any action
to facilitate a Takeover Proposal (other than by Parent or its subsidiaries).</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section5_15_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
5.15.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Stockholders Agreement Legend.</u>&#160;
The Company shall inscribe upon any Certificate representing Subject
Shares tendered by a Stockholder (as such terms are defined in the Stockholders
Agreement) in connection with any proposed transfer of any Subject Shares by
such Stockholder in accordance with the Stockholders Agreement the following
legend:&#160; &#147;THE SHARES OF COMMON STOCK,
PAR VALUE $.001 PER SHARE, OF COLLATERAL THERAPEUTICS, INC. REPRESENTED BY THIS
CERTIFICATE ARE SUBJECT TO A STOCKHOLDERS AGREEMENT DATED AS OF March 19, 2002,
AND ARE SUBJECT TO TERMS THEREOF.&#160;
COPIES OF SUCH AGREEMENT MAY BE OBTAINED AT THE PRINCIPAL EXECUTIVE
OFFICES OF COLLATERAL THERAPEUTICS, INC.&#148;.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section5_16_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
5.16.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Transfer Taxes.</u>&#160; All stock
transfer, real estate transfer, documentary, stamp, recording and other similar
taxes (including interest, penalties and additions to any such taxes) incurred
in connection with this Agreement and the transactions contemplated by this
Agreement shall be paid by the Surviving Company.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section5_17_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
5.17.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Further Assurances.</u>&#160; The
Company shall deliver, or shall cause to be delivered, if required by the terms
of any note, indenture, credit agreement, warrant or other financing instrument
or preferred stock, as promptly as possible after the date of this Agreement
but in no event less than 15&nbsp;days prior to the Effective Time, any notice
of the Merger or the transactions contemplated by this Agreement.&#160; The Company shall, with reasonable
promptness, take such further actions and furnish such further information as
Parent may reasonably request in accordance with applicable laws in order to
carry out the transactions contemplated by this Agreement and the Stockholders
Agreement.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section5_18_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
5.18.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Section 16 Matters.</u>&#160; Prior
to the Effective Time, Parent and the Company shall use commercially reasonable
efforts to take all such steps as may be required to cause any dispositions of
Company Common Stock (including derivative securities in respect to Company
Common Stock) resulting from the transactions contemplated by Article&nbsp;I,
Article&nbsp;II or Section&nbsp;5.06 of this Agreement by each individual who
is subject to the reporting requirements of Section&nbsp;16(a) of </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=60,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=628061,FOLIO='55',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">56</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">the
Exchange Act with respect to the Company, to be exempt under Rule&nbsp;16b-3
promulgated under the Exchange Act.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section5_19_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
5.19.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Parent ADSs.</u>&#160; Prior to the
Effective Time, Parent shall use its commercially reasonable efforts to obtain
the Parent Share Authorization.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><a name="ArticleVi"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE
VI</font></a></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><a name="ConditionsPrecedent"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Conditions Precedent</font></u></a></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section6_01_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
6.01.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Conditions to Each Party&#146;s Obligation to Effect the Merger.</u>&#160; The respective obligation of each party
hereto to effect the Merger is subject to the satisfaction or waiver on or
prior to the Closing Date of the following conditions:</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;
<u>Company Stockholder Approval.</u>&#160;
The Company Stockholder Approval shall have been obtained.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;
<u>NYSE Listing.</u>&#160; The Parent
ADSs issuable to the Company&#146;s stockholders as contemplated by this Agreement
shall have been approved for listing on the NYSE, subject to official notice of
issuance.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;
<u>Antitrust.</u>&#160; The waiting
period (and any extension thereof) applicable to the Merger under the HSR Act
shall have been terminated or shall have expired and all applicable filings
shall have been made and all applicable approvals shall have been obtained
under similar foreign antitrust or competition laws and regulations.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;
<u>No Injunctions.</u>&#160; No
judgment, order, decree, statute, law, ordinance, rule or regulation entered,
enacted, promulgated, enforced or issued by any court or other Governmental
Entity of competent jurisdiction or other legal restraint or prohibition
(collectively, &#147;Restraints&#148;) shall be in effect, and there shall not be pending
or threatened any suit, claim, action or proceeding by any Governmental Entity
(i)&nbsp;preventing the consummation of the Merger or (ii)&nbsp;which otherwise
has had or would reasonably be expected to have a Company Material Adverse
Effect or a Parent Material Adverse Effect as applicable, or to materially
impair the benefits intended to be </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=61,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=64174,FOLIO='56',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">57</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">obtained by Parent in the Merger; <u>provided</u>,
<u>however</u>, that each of the parties hereto shall have used its
commercially reasonable efforts to prevent the entry of any such Restraints and
to appeal as promptly as possible any such Restraints that may be entered.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)&#160;
<u>Form F-4.</u>&#160; The
Form&nbsp;F-4 shall have become effective under the Securities Act and shall
not be the subject of any stop order or proceedings seeking a stop order.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f) <u>Parent Share Authorization</u>.&#160; The Parent Share Authorization shall have
been obtained.</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section6_02_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
6.02.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Conditions to Obligations of Parent and Sub.</u>&#160; The obligations of Parent and Sub to effect
the Merger are further subject to the satisfaction or waiver on or prior to the
Closing Date of the following conditions:</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&nbsp;&nbsp;<u>Representations
and Warranties.</u>&#160; The representations
and warranties of the Company contained in this Agreement that are qualified as
to materiality shall be true and correct, and the representations and
warranties of the Company contained in this Agreement that are not so qualified
shall be true and correct in all material respects, in each case as of the date
of this Agreement and as of the Closing Date as though made on the Closing
Date, except to the extent such representations and warranties expressly relate
to an earlier date, in which case as of such earlier date. Parent shall have
received a certificate signed on behalf of the Company by the chief executive
officer and the chief financial officer of the Company to such effect.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;
<u>Performance of Obligations of the Company.</u>&#160; The Company shall have performed in all
material respects all obligations required to be performed by it under this
Agreement at or prior to the Closing Date.&#160;
Parent shall have received a certificate signed on behalf of the Company
by the chief executive officer and the chief financial officer of the Company
to such effect.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Repayment
of Executive Loans.&#160; </u>The outstanding
Executive Loans identified in Section 3.01(i) of the Company Disclosure
Schedule in the </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=62,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=395878,FOLIO='57',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">58</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">aggregate
principal amount of $1.2 million issued by the Company to certain of its
executive officers shall have been repaid to the Company in full through the
delivery by such executive officers to the Company of the aggregate number of
shares of Company Common Stock set forth on Schedule 6.02(c) of the Company
Disclosure Schedule.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section6_03_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
6.03.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Conditions to Obligation of the Company.</u>&#160; The obligation of the Company to effect the
Merger is further subject to the satisfaction or waiver on or prior to the
Closing Date of the following conditions:</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;
<u>Representations and Warranties.</u>&#160;
The representations and warranties of Parent and Sub contained in this
Agreement that are qualified as to materiality shall be true and correct, and
the representations and warranties of Parent and Sub contained in this
Agreement that are not so qualified shall be true and correct in all material
respects, in each case as of the date of this Agreement and as of the Closing
Date as though made on the Closing Date, except to the extent such
representations and warranties expressly relate to an earlier date, in which
case as of such earlier date.&#160; The
Company shall have received a certificate signed on behalf of Parent by an
executive officer of Parent to such effect.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;
<u>Performance of Obligations of Parent and Sub.</u>&#160; Parent and Sub shall have performed in all
material respects all obligations required to be performed by them under this
Agreement at or prior to the Closing Date.&#160;
The Company shall have received a certificate signed on behalf of Parent
by an executive officer of Parent to such effect.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;
<u>Tax Opinion.</u>&#160; The Company
shall have received from Coudert Brothers LLP, tax counsel to the Company, on
the date on which the Form&nbsp;F-4 is filed with the SEC and on the Closing
Date, an opinion, in each case dated as of such respective date and to the
effect that (i)&nbsp;the Merger will qualify for U.S. Federal income tax purposes
as a &#147;reorganization&#148; within the meaning of Section&nbsp;368(a) of the Code,
(ii)&nbsp;the Company, Parent and Sub will each be a &#147;party to a
reorganization&#148; within the meaning of Section&nbsp;368(b) of the Code and (iii)
no gain or loss will be recognized by the Company stockholders who exchange
Company Common Stock solely for Parent ADSs pursuant to the </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=63,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=621488,FOLIO='58',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">59</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Merger (except with respect to (x) any cash
received in lieu of fractional Parent ADSs and (y) Company stockholders who are
not Eligible Company Stockholders). </font><b><font size="2" style="font-size:10.0pt;font-weight:bold;">&#160;</font></b><font size="2" style="font-size:10.0pt;">The
issuance of such opinion may be conditioned upon the receipt by</font><b><font size="2" style="font-size:10.0pt;font-weight:bold;">  </font></b><font size="2" style="font-size:10.0pt;">such
tax counsel of representation letters from each of Parent and the Company
substantially in the form of Exhibits C-1 and C-2 to this Agreement.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section6_04_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
6.04.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Frustration of Closing Conditions.</u>&#160; None of the Company, Parent or Sub may rely on the failure of any
condition set forth in Section&nbsp;6.01, 6.02 or 6.03, as the case may be, to
be satisfied if such failure was caused by such party&#146;s failure to act in good
faith or to comply with its obligations under Section&nbsp;5.05.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><a name="ArticleVii"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE
VII</font></a></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Termination,
Amendment and Waiver</font></u></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section7_01_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
7.01.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Termination.</u>&#160; This
Agreement may be terminated at any time prior to the Effective Time, whether
before or after receipt of the Company Stockholder Approval:</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&nbsp;&nbsp;by mutual written
consent of Parent, Sub and the Company;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&nbsp;&nbsp;by either Parent or
the Company:</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i) if the Merger shall not have
been consummated on or before September 1, 2002; <u>provided</u>, <u>however</u>,
that the right to terminate this Agreement under this Section&nbsp;7.01(b)(i)
shall not be available to any party whose action or failure to act has been a
principal cause of or resulted in the failure of the Merger to be consummated
on or before such date;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii) if any Restraint having any of
the effects set forth in Section&nbsp;6.01(d) shall be in effect and shall have
become final and nonappealable; <u>provided</u> that the party seeking to
terminate the Agreement pursuant to this Section&nbsp;7.01(b)(ii) shall have
used commercially reasonable efforts to prevent the entry of and to remove such
Restraint;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=64,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=1010013,FOLIO='59',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">60</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.0in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii) if the Company Stockholder
Approval shall not have been obtained at the Company Stockholders&#146; Meeting duly
convened therefor or at any adjournment or postponement thereof; or</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)&#160; if the Parent Shareholder Approval shall not have been obtained
at the Parent Shareholders&#146;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Meeting duly convened therefor or at any
adjournment or postponement thereof;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&nbsp;by Parent, if the Company
shall have breached or failed to perform any of its representations,
warranties, covenants or other agreements set forth in this Agreement, which
breach or failure to perform (i)&nbsp;would give rise to the failure of a
condition set forth in Section&nbsp;6.02(a) or 6.02(b) and (ii)&nbsp;has not
been or is incapable of being cured by the Company within 30&nbsp;calendar days
following its receipt of written notice of such breach or failure to perform
from Parent;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d) by the Company, if Parent shall
have breached or failed to perform any of its representations, warranties,
covenants or other agreements set forth in this Agreement, which breach or
failure to perform (i)&nbsp;would give rise to the failure of a condition set
forth in Section&nbsp;6.03(a) or 6.03(b) and (ii)&nbsp;has not been or is
incapable of being cured by Parent within 30&nbsp;calendar days following its
receipt of written notice of such breach or failure to perform from the
Company;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e) by Parent in the event an
Adverse Recommendation has occurred; or</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f) by the Company in accordance with the
terms and subject to the conditions of Section 4.02(b).</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section7_02_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
7.02.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Effect of Termination.</u>&#160; In
the event of termination of this Agreement by either the Company or Parent as
provided in Section&nbsp;7.01, this Agreement shall forthwith become void and
have no effect, without any liability or obligation on the part of Parent, Sub
or the Company, other than the provisions of Section&nbsp;3.01(r), the second
sentence of Section&nbsp;5.04, Section&nbsp;5.08, this Section&nbsp;7.02 and Article&nbsp;VIII,
which provisions shall survive such termination, and except to the extent that
such termination results from the wilful and </font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=65,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=379949,FOLIO='60',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">61</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">material
breach by a party of any of its representations, warranties, covenants or
agreements set forth in this Agreement, including Section&nbsp;4.02.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section7_03_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
7.03.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Amendment.</u>&#160; This Agreement
may be amended by the parties hereto at any time before or after the receipt of
Company Stockholder Approval; <u>provided</u>, <u>however</u>, that after such
approval has been obtained, there shall be made no amendment that by law
requires further approval by the stockholders of the Company or the approval of
the shareholders of Parent without such further approval having been obtained.&#160; This Agreement may not be amended except by
an instrument in writing signed on behalf of each of the parties hereto.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section7_04_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
7.04.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Extension; Waiver.</u>&#160; At any
time prior to the Effective Time, a party hereto may (a)&nbsp;extend the time
for the performance of any of the obligations or other acts of the other
parties, (b)&nbsp;waive any inaccuracies in the representations and warranties
of the other parties contained herein or in any document delivered pursuant
hereto or (c)&nbsp;subject to the proviso to the first sentence of Section&nbsp;7.03,
waive compliance of the other parties with any of the agreements or conditions
contained herein.&#160; Any agreement on the
part of a party hereto to any such extension or waiver shall be valid only if
set forth in an instrument in writing signed on behalf of such party.&#160; The failure of any party hereto to assert
any of its rights under this Agreement or otherwise shall not constitute a
waiver of such rights.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><a name="ArticleViii"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE VIII</font></a></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><a name="GeneralProvisions"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">General Provisions</font></u></a></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section8_01_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
8.01.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Nonsurvival of Representations and Warranties.</u>&#160; None of the representations, warranties,
covenants or agreements contained in this Agreement or in any instrument
delivered pursuant to this Agreement shall survive the Effective Time.&#160; This Section&nbsp;8.01 shall not limit any
covenant or agreement of the parties hereto which by its terms contemplates
performance after the Effective Time.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section8_02_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
8.02.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Notices.</u>&#160; All notices,
requests, claims, demands and other communications hereunder shall be in
writing and shall be deemed given if delivered personally, </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=66,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=673376,FOLIO='61',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">62</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">telecopied
(which is confirmed) or sent by an internationally recognized overnight courier
(providing proof of delivery) to the parties hereto at the following addresses
(or at such other address for a party as shall be specified by like notice):</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">if to Parent or Sub, to:</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Schering Aktiengesellschaft</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">M&#252;llerstr. 178</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13353 Berlin, Germany</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Telecopy No.:&#160; 49-30-468-14086</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attention: General Counsel</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">with copies to:</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Schering Berlex Inc.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">340 Changebridge Road</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Montville, New Jersey 07045</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Telecopy No.: (973) 487-2712</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attention: General Counsel</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:2.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#160;&#160;
and</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cravath, Swaine &amp; Moore</font></p>

<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Worldwide Plaza</font></p>

<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">825 Eighth Avenue</font></p>

<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">New York, New York 10019</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Telecopy No.:&#160; (212) 474-3700</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attention:&#160;
Mark I. Greene, Esq.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">if to the Company, to:</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Collateral Therapeutics, Inc.</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11622 El Camino Real</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">San Diego, California 92130</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Telecopy No.:&#160; (858) 794-3460</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=67,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=752131,FOLIO='62',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">63</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attention:&#160;
Tyler Dylan, Esq.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">with a copy to:</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Coudert Brothers LLP</font></p>

<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1114 Avenue of the Americas</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">New York, New York 10036</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Telecopy No.:&#160; (212) 626-4120</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attention:&#160;
Jeffrey E. Cohen, Esq.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section8_03_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
8.03.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Definitions.</u>&#160; For purposes
of this Agreement:</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&nbsp;an &#147;Affiliate&#148; of any
person means another person that directly or indirectly, through one or more
intermediaries, controls, is controlled by, or is under common control with,
such first person, where &#147;control&#148; means the possession, direct or indirect, of
the power to direct or cause the direction of the management and policies of a
person, whether through the ownership of voting securities, by contract, as
trustee or executor, or otherwise;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b) &#147;Business Day&#148; means any day
other than Saturday, Sunday or any other day on which banks are legally
permitted to be closed in New York or in the Federal Republic of Germany;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&nbsp;&nbsp;&#148;Knowledge&#148; of any
person that is not an individual means, with respect to any matter in question,
the actual knowledge of such person&#146;s executive officers and other officers
having primary responsibility for such matter, in each case after due inquiry;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&nbsp;&nbsp;&#148;Company Material
Adverse Change&#148; or &#147;Company Material Adverse Effect&#148; means any state of facts,
change, development, effect, condition or occurrence that would reasonably be
expected to be material and adverse to the (a) business, (b) assets, (c)
properties, (d) condition (financial or otherwise) or (e) results of operations
of the Company, other than any state of facts, change, development, effect,
condition or occurrence (x) relating </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=68,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=177783,FOLIO='63',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">64</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">to the economy in general or the United
States equity capital markets in general or (y) relating to the pharmaceutical
or biotechnical industry in general and not specifically relating to the
Company;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)&nbsp;&nbsp;&#147;Parent Material Adverse
Change&#148; or &#147;Parent Material Adverse Effect&#148; means any state of facts, change,
development, effect, condition or occurrence that would reasonably be expected
to be material and adverse to the (a) business, (b) assets, (c) properties, (d)
condition (financial or otherwise) or (e) results of operations of Parent and
its subsidiaries, taken as a whole , other than any state of facts, change,
development, effect, condition or occurrence (x) relating to the economy in
general or the United States or the German equity capital markets in general or
(y) relating to Parent&#146;s and its subsidiaries&#146; industries in general and not
specifically relating to Parent;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)&nbsp;&nbsp;&#147;person&#148; means an
individual, corporation, partnership, limited liability company, joint venture,
 association, trust, unincorporated
organization or other entity; and</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)&nbsp;&nbsp;a &#147;subsidiary&#148; of any
person means another person, an amount of the voting securities, other voting
rights or voting partnership interests of which is sufficient to elect at least
a majority of its board of directors or other governing body (or, if there are
no such voting interests, 50% or more of the equity interests of which) is
owned directly or indirectly by such first person.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section8_04_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
8.04.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Interpretation.</u>&#160; When a
reference is made in this Agreement to an Article, Section, Exhibit or
Schedule, such reference shall be to an Article of, a Section of, or an Exhibit
or Schedule to, this Agreement unless otherwise indicated.&#160; The table of contents and headings contained
in this Agreement are for reference purposes only and shall not affect in any
way the meaning or interpretation of this Agreement.&#160; Whenever the words &#147;include&#148;, &#147;includes&#148; or &#147;including&#148; are used
in this Agreement, they shall be deemed to be followed by the words &#147;without
limitation&#148;.&#160; The words &#147;hereof&#148;,
&#147;herein&#148; and &#147;hereunder&#148; and words of similar import when used in this
Agreement shall refer to this Agreement as a </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=69,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=400005,FOLIO='64',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">65</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">whole
and not to any particular provision of this Agreement.&#160; All terms defined in this Agreement shall
have the defined meanings when used in any certificate or other document made
or delivered pursuant hereto unless otherwise defined therein.&#160; The definitions contained in this Agreement
are applicable to the singular as well as the plural forms of such terms and to
the masculine as well as to the feminine and neuter genders of such term.&#160; Any agreement, instrument or statute defined
or referred to herein or in any agreement or instrument that is referred to
herein means such agreement, instrument or statute as from time to time
amended, modified or supplemented, including (in the case of agreements or
instruments) by waiver or consent and (in the case of statutes) by succession
of comparable successor statutes and references to all attachments thereto and
instruments incorporated therein.&#160;
References to a person are also to its permitted successors and
assigns.&#160; Terms used herein that are
defined under GAAP are used herein as so defined.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section8_05_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION 8.05.</font></a><font size="2" style="font-size:10.0pt;">&#160; <u>Counterparts.</u>&#160; This Agreement may be executed in one or
more counterparts, all of which shall be considered one and the same agreement
and shall become effective when one or more counterparts have been signed by
each of the parties hereto and delivered to the other parties.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section8_06_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
8.06.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Entire Agreement; No Third-Party Beneficiaries.</u>&#160; This Agreement (including the documents and
instruments referred to herein), the Stockholders Agreement and the
Confidentiality Agreement (a)&nbsp;constitute the entire agreement, and
supersede all prior agreements and understandings, both written and oral, among
the parties hereto with respect to the subject matter of this Agreement, the
Stockholders Agreement and the Confidentiality Agreement and (b)&nbsp;except
for the provisions of Article&nbsp;II and Section&nbsp;5.07, are not intended
to confer upon any person other than the parties hereto any rights or remedies.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section8_07_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
8.07.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Governing Law.</u>&#160; This
Agreement shall be governed by, and construed in accordance with, the laws of
the State of Delaware, regardless of the laws that might otherwise govern under
applicable principles of conflicts of laws thereof.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section8_08_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
8.08.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Assignment.</u>&#160; Neither this
Agreement nor any of the rights, interests or obligations under this Agreement
shall be assigned, in whole or in part, by operation of law or otherwise by any
of the parties hereto without the prior written </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=70,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=868012,FOLIO='65',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">66</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">consent
of the other parties, except that Sub may assign, in its sole discretion, any
of or all its rights, interests and obligations under this Agreement to Parent
or to any direct or indirect wholly owned subsidiary of Parent, but no such
assignment shall relieve Sub of any of its obligations under this Agreement.&#160; Any purported assignment in violation of
this Section 8.08 shall be void.&#160;
Subject to the preceding sentences, this Agreement shall be binding
upon, inure to the benefit of, and be enforceable by, the parties hereto and
their respective permitted successors and assigns.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section8_09_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
8.09.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Enforcement; Consent to Jurisdiction.</u>&#160; The parties hereto agree that irreparable damage would occur and
that the parties would not have any adequate remedy at law in the event that
any of the provisions of this Agreement were not performed in accordance with
their specific terms or were otherwise breached.&#160; It is accordingly agreed that the parties hereto shall be
entitled to an injunction or injunctions to prevent breaches of this Agreement
and to enforce specifically the terms and provisions of this Agreement in any
Delaware state court or any Federal court located in the State of Delaware,
this being in addition to any other remedy to which they are entitled at law or
in equity.&#160; In addition, each of the
parties hereto (a)&nbsp;consents to submit itself to the personal jurisdiction
of any Delaware state court or any Federal court located in the State of
Delaware in the event any dispute arises out of this Agreement or any of the
transactions contemplated by this Agreement, (b)&nbsp;agrees that it shall not
attempt to deny or defeat such personal jurisdiction by motion or other request
for leave from any such court, (c)&nbsp;agrees that it shall not bring any
action relating to this Agreement or any of the transactions contemplated by
this Agreement in any court other than a Delaware state court or a Federal
court located in the State of Delaware, (d) waives any right to trial by jury
with respect to any action relating to this Agreement or any of the
transactions contemplated by this Agreement in any Delaware state court or any
Federal court located in the State of Delaware and (e) hereby unconditionally
waives and agrees not to plead or claim in any such court that any such action
brought in any such court has been brought in an inconvenient forum.&#160; Parent hereby irrevocably appoints CT
Corporation, 111 Eighth Avenue, New York, New York 10011 as its agent for
service of process in connection with any action brought against it relating to
this Agreement and the Stockholders Agreement.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=71,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=673731,FOLIO='66',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">67</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><a name="Section8_10_"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION
8.10.</font></a><font size="2" style="font-size:10.0pt;">&#160;
<u>Severability.</u>&#160; If any term
or other provision of this Agreement is invalid, illegal or incapable of being
enforced by any rule of law or public policy, all other conditions and
provisions of this Agreement shall nevertheless remain in full force and
effect.&#160; Upon such determination that
any term or other provision is invalid, illegal or incapable of being enforced,
the parties hereto shall negotiate in good faith to modify this Agreement so as
to effect the original intent of the parties as closely as possible to the
fullest extent permitted by applicable law in an acceptable manner to the end
that the transactions contemplated by this Agreement are fulfilled to the
extent possible.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">IN WITNESS WHEREOF, Parent, Sub and the
Company have caused this Agreement to be signed by their respective officers
thereunto duly authorized, all as of the date first written above.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="36%" valign="top" style="padding:0in .7pt 0in .7pt;width:36.72%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="51%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:51.84%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SCHERING
  AKTIENGESELLSCHAFT,</font></p>
  </td>
  <td width="11%" valign="top" style="padding:0in .7pt 0in .7pt;width:11.44%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="36%" valign="top" style="padding:0in .7pt 0in .7pt;width:36.72%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.14%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.16%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" valign="top" style="padding:0in .7pt 0in .7pt;width:43.54%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="11%" valign="top" style="padding:0in .7pt 0in .7pt;width:11.44%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="36%" valign="top" style="padding:0in .7pt 0in .7pt;width:36.72%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.14%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.16%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">by</font></p>
  </td>
  <td width="43%" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in .7pt 0in .7pt;width:43.54%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Klaus Pohle</font></p>
  </td>
  <td width="11%" valign="top" style="padding:0in .7pt 0in .7pt;width:11.44%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="36%" valign="top" style="padding:0in .7pt 0in .7pt;width:36.72%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.14%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.16%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" valign="top" style="padding:0in .7pt 0in .7pt;width:43.54%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:
  Klaus Pohle</font></p>
  </td>
  <td width="11%" valign="top" style="padding:0in .7pt 0in .7pt;width:11.44%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="36%" valign="top" style="padding:0in .7pt 0in .7pt;width:36.72%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.14%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.16%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" valign="top" style="padding:0in .7pt 0in .7pt;width:43.54%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:Vice
  Chairman</font></p>
  </td>
  <td width="11%" valign="top" style="padding:0in .7pt 0in .7pt;width:11.44%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="36%" valign="top" style="padding:0in .7pt 0in .7pt;width:36.72%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.14%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.16%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" valign="top" style="padding:0in .7pt 0in .7pt;width:43.54%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="11%" valign="top" style="padding:0in .7pt 0in .7pt;width:11.44%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="36%" valign="top" style="padding:0in .7pt 0in .7pt;width:36.72%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.14%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.16%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">by</font></p>
  </td>
  <td width="43%" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in .7pt 0in .7pt;width:43.54%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/
  Illona Murati-Laebe</font></p>
  </td>
  <td width="11%" valign="top" style="padding:0in .7pt 0in .7pt;width:11.44%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="36%" valign="top" style="padding:0in .7pt 0in .7pt;width:36.72%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.14%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.16%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" valign="top" style="border:none;padding:0in .7pt 0in .7pt;width:43.54%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:
  Illona Murati-Laebe</font></p>
  </td>
  <td width="11%" valign="top" style="padding:0in .7pt 0in .7pt;width:11.44%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="36%" valign="top" style="padding:0in .7pt 0in .7pt;width:36.72%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.14%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.16%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" valign="top" style="padding:0in .7pt 0in .7pt;width:43.54%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:
  Legal Counsel</font></p>
  </td>
  <td width="11%" valign="top" style="padding:0in .7pt 0in .7pt;width:11.44%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="36%" valign="top" style="padding:0in .7pt 0in .7pt;width:36.72%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.14%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.16%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" valign="top" style="padding:0in .7pt 0in .7pt;width:43.54%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="11%" valign="top" style="padding:0in .7pt 0in .7pt;width:11.44%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="36%" valign="top" style="padding:0in .7pt 0in .7pt;width:36.72%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="51%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:51.84%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">EUROPEAN
  ACQUISITION COMPANY,</font></p>
  </td>
  <td width="11%" valign="top" style="padding:0in .7pt 0in .7pt;width:11.44%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="36%" valign="top" style="padding:0in .7pt 0in .7pt;width:36.72%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.14%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.16%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" valign="top" style="padding:0in .7pt 0in .7pt;width:43.54%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="11%" valign="top" style="padding:0in .7pt 0in .7pt;width:11.44%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="36%" valign="top" style="padding:0in .7pt 0in .7pt;width:36.72%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.14%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.16%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">by</font></p>
  </td>
  <td width="43%" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in .7pt 0in .7pt;width:43.54%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Horst Krueger</font></p>
  </td>
  <td width="11%" valign="top" style="padding:0in .7pt 0in .7pt;width:11.44%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="36%" valign="top" style="padding:0in .7pt 0in .7pt;width:36.72%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.14%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.16%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" valign="top" style="padding:0in .7pt 0in .7pt;width:43.54%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:
  Horst Krueger</font></p>
  </td>
  <td width="11%" valign="top" style="padding:0in .7pt 0in .7pt;width:11.44%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="36%" valign="top" style="padding:0in .7pt 0in .7pt;width:36.72%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.14%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.16%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" valign="top" style="padding:0in .7pt 0in .7pt;width:43.54%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:
  Director and Chairman</font></p>
  </td>
  <td width="11%" valign="top" style="padding:0in .7pt 0in .7pt;width:11.44%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="36%" valign="top" style="padding:0in .7pt 0in .7pt;width:36.72%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.14%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.16%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" valign="top" style="padding:0in .7pt 0in .7pt;width:43.54%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="11%" valign="top" style="padding:0in .7pt 0in .7pt;width:11.44%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="36%" valign="top" style="padding:0in .7pt 0in .7pt;width:36.72%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="51%" colspan="3" valign="top" style="padding:0in .7pt 0in .7pt;width:51.84%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">COLLATERAL
  THERAPEUTICS, INC.,</font></p>
  </td>
  <td width="11%" valign="top" style="padding:0in .7pt 0in .7pt;width:11.44%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="36%" valign="top" style="padding:0in .7pt 0in .7pt;width:36.72%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.14%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.16%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" valign="top" style="padding:0in .7pt 0in .7pt;width:43.54%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="11%" valign="top" style="padding:0in .7pt 0in .7pt;width:11.44%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="36%" valign="top" style="padding:0in .7pt 0in .7pt;width:36.72%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.14%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.16%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">by</font></p>
  </td>
  <td width="43%" valign="top" style="border:none;border-bottom:solid windowtext .5pt;padding:0in .7pt 0in .7pt;width:43.54%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Jack W. Reich, Ph.D.</font></p>
  </td>
  <td width="11%" valign="top" style="padding:0in .7pt 0in .7pt;width:11.44%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="36%" valign="top" style="padding:0in .7pt 0in .7pt;width:36.72%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.14%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.16%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" valign="top" style="padding:0in .7pt 0in .7pt;width:43.54%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:
  Jack W. Reich</font></p>
  </td>
  <td width="11%" valign="top" style="padding:0in .7pt 0in .7pt;width:11.44%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="36%" valign="top" style="padding:0in .7pt 0in .7pt;width:36.72%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.14%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.16%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" valign="top" style="padding:0in .7pt 0in .7pt;width:43.54%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:
  Chairman and Chief Executive Officer</font></p>
  </td>
  <td width="11%" valign="top" style="padding:0in .7pt 0in .7pt;width:11.44%;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="36%" valign="top" style="padding:0in .7pt 0in .7pt;width:36.72%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.14%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="4%" valign="top" style="padding:0in .7pt 0in .7pt;width:4.16%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="43%" valign="top" style="padding:0in .7pt 0in .7pt;width:43.54%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="11%" valign="top" style="padding:0in .7pt 0in .7pt;width:11.44%;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=72,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=812610,FOLIO='67',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">68</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ANNEX&nbsp;I</font></p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TO THE MERGER AGREEMENT</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Index of Defined Terms</font></u></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><a name="Table"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Term</font></u></a></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="230" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:172.85pt;">
  <p align="right" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;">&nbsp;</p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="230" valign="bottom" style="padding:0in .7pt 0in .7pt;width:172.85pt;">
  <p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Acquisition
  Agreement</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  4.02(b</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Adverse
  Recommendation</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  4.02(b</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Affiliate</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  8.03(a</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Agreement</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preamble</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Benefit
  Agreements</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(g</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Benefit
  Plans</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(l</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Business
  Day</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  8.03(b</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Certificate</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  2.01(c</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Certificate
  of Merger</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  1.03</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Closing</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  1.02</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Closing
  Date</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  1.02</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Code</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preamble</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preamble</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company
  By-laws</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(a</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company
  Certificate</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(a</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company
  Common Stock</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preamble</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company
  Disclosure Schedule</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company
  Material Adverse Change</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  8.03(d</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company
  Material Adverse Effect</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  8.03(d</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company
  SEC Documents</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(e</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company
  Stock Plans</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  5.06(a</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company
  Stockholder Approval</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(p</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company
  Stockholders&#146; Meeting</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  5.01(b</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company
  Stock Options</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(c</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Confidentiality
  Agreement</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  5.04</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Depositary</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  2.01(c</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Deposit
  Agreement</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  2.01(c</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">DGCL</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  1.01</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Effective
  Time</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  1.03</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Eligible
  Company Stockholders</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preamble</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Environmental
  Laws</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(j</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ERISA</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(l</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exchange
  Act</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(d</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exchange
  Agent</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  2.02(a</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exchange
  Fund</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  2.02(a</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exchange
  Ratio</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  2.01(c</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">FDA</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(j</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">FDCA</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(j</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Filed
  Company SEC Documents</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(e</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Form
  F-4</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(f</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=73,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=50431,FOLIO='68',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">69</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">GAAP</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(e</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Governmental
  Entity</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(d</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Hazardous
  Material</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(j</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">HSR
  Act</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(d</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Intellectual
  Property Rights</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(o</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">IRS</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(l</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Knowledge</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  8.03(c</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Legal
  Provisions</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(j</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;">&nbsp;</p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:12.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="230" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:172.85pt;">
  <p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Term</font></u></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="230" valign="bottom" style="padding:0in .7pt 0in .7pt;width:172.85pt;">
  <p align="right" style="font-size:1.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Liens</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(d</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Merger</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preamble</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Merger
  Consideration</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  2.01(c</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notice
  of Superior Proposal</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  4.02(b</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">NYSE</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.02(c</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Parent</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preamble</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Parent
  ADR</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  2.01(c</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Parent
  ADS</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  2.01(c</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Parent
  Material Adverse Change</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  8.03(e</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Parent
  Material Adverse Effect</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  8.03(e</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Parent
  Ordinary Share</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  2.01(c</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Parent
  SEC Documents</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.02(d</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Parent
  Share Authorization</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.02(c</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Parent
  Shareholder Approval</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.02(c</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Parent
  Shareholders&#146; Meeting</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.02(c</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Participant</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(g</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Permits</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(j</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">person</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  8.03(f</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pharmaceutical
  Product</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(u</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Post-Signing
  Returns</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  4.01(d</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preferred
  Stock</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(c</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Principal
  Stockholders</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preamble</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Proxy
  Statement</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(d</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Purchase
  Interval</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  5.06(b</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Release</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(j</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Representatives</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  4.02(a</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Restraints</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  6.01(d</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Rights</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  5.14</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Rights
  Agreement</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(t</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SBI</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preamble</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SEC</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(d</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Securities
  Act</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(e</font><font size="2" style="font-size:10.0pt;">)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Stockholders
  Agreement</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preamble</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sub</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preamble</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">subsidiary</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  8.03(g)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Superior
  Proposal</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  4.02(a)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Surviving
  Corporation</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  1.01</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Surviving
  Corporation Common Stock</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  2.01(a)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Takeover
  Proposal</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" colspan="2" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  4.02(a)</font></p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=74,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=972187,FOLIO='69',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

<p align="right" style="font-size:12.0pt;margin:0in 0in .0001pt;text-align:right;">&nbsp;</p>

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">70</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="492" valign="top" style="padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">taxes</font></p>
  </td>
  <td width="20" valign="bottom" style="padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" valign="bottom" style="padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  3.01(m)</font></p>
  </td>
 </tr>
 <tr>
  <td width="492" valign="top" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:368.65pt;">
  <p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Termination
  Fee</font></p>
  </td>
  <td width="20" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:15.0pt;">
  <p style="font-size:1.0pt;margin:0in 0in .0001pt;">&nbsp;</p>
  </td>
  <td width="250" valign="bottom" bgcolor="#cceeff" style="background:#CCEEFF;padding:0in .7pt 0in .7pt;width:187.85pt;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section
  5.08(b)</font></p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>


<div style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">

<hr size="2" width="100%" noshade color="gray" align="left">

</font></div>

<font size="2" face="Times New Roman" style="font-size:10.0pt;">
<!-- ZEQ.=1,SEQ=75,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2",CHK=1039978,FOLIO='70',FILE="DISK018:[02SAN9.02SAN1249.EDGAR]EX2-1_1249.CHC",USER="AHANSON",CD='Mar 20 19:22 2002' -->
<br clear="all" style="page-break-before:always;">
</font>

</div>

<BR>
<!-- SEQ=,FILE='QUICKLINK',USER=AHANSON,SEQ=,EFW="2073992",CP="COLLATERAL THERAPEUTICS, INC.",DN="2" -->
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>

</TEXT>
</DOCUMENT>
